0001255294-12-000308.txt : 20120515 0001255294-12-000308.hdr.sgml : 20120515 20120515113755 ACCESSION NUMBER: 0001255294-12-000308 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OptimizeRx Corp CENTRAL INDEX KEY: 0001448431 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 261265381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53605 FILM NUMBER: 12842255 BUSINESS ADDRESS: STREET 1: 400 WATER ST., STE. 200 CITY: ROCHESTER STATE: MI ZIP: 48307 BUSINESS PHONE: 248-651-6558 MAIL ADDRESS: STREET 1: 400 WATER ST., STE. 200 CITY: ROCHESTER STATE: MI ZIP: 48307 10-Q 1 mainbody.htm MAINBODY

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

[X]	Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	For the quarterly period ended March 31, 2012

[ ]	Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

	For the transition period from __________ to __________

	Commission File Number: 000-53605

OptimizeRx Corporation

(Exact name of registrant as specified in its charter)

Nevada	26-1265381
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
407 6th Street Rochester, MI, 48307
(Address of principal executive offices)

248-651-6568

(Registrant's telephone number)

_______________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days

[X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

[ ] Large accelerated filer Accelerated filer	[ ] Non-accelerated filer
[X] Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 14,192,496 as of March 31, 2012.

Table of Contents

	TABLE OF CONTENTS	Page
PART I – FINANCIAL INFORMATION
Item 1:	Financial Statements	3
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3:	Quantitative and Qualitative Disclosures About Market Risk	9
Item 4:	Controls and Procedures	9
PART II – OTHER INFORMATION
Item 1:	Legal Proceedings	10
Item 1A:	Risk Factors	10
Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds	10
Item 3:	Defaults Upon Senior Securities	10
Item 4:	Mine Safety Disclosure	10
Item 5:	Other Information	10
Item 6:	Exhibits	10

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Our consolidated financial statements included in this Form 10-Q are as follows:

F-1	Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011;
F-2	Consolidated Statements of Operations for the three months ended March 31, 2012 and 2011;
F-3	Consolidated Statements of Cash Flow for the three months ended March 31, 2012 and 2011;
F-4	Notes to Consolidated Financial Statements.

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended March 31, 2012 are not necessarily indicative of the results that can be expected for the full year.

Table of Contents

OPTIMIZERx CORPORATION

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

AS OF MARCH 31, 2012 AND DECEMBER 31, 2011

ASSETS
	March 31,			December 31,
	2012			2011
Current Assets
Cash and cash equivalents	$	797,503		$	959,166
Accounts receivable		116,458			471,870
Prepaid expenses		114,000			119,032
Total Current Assets		1,027,961			1,550,068

Property and equipment, net		24,055			23,931

Other Assets
Patent rights, net		834,265			847,941
Website development costs, net		466,686			465,498
Security deposit		5,049			5,049
Total Other Assets		1,306,000			1,318,488

TOTAL ASSETS	$	2,358,016		$	2,892,487

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
Accounts payable - trade	$	176,051		$	336,712
Accounts payable - related party		570,000			570,000
Accrued expenses		322			66,000
Deferred revenue		203,153			330,605
Total Current Liabilities		949,526			1,303,317

Stockholders' Equity
Common stock, $.001 par value, 500,000,000 shares authorized, 14,192,496 shares issued and outstanding		14,192			14,192
Preferred stock, $.001 par value, 10,000,000 shares authorized, 65 shares issued and outstanding		-0-			-0-
Stock warrants		20,826,934			20,826,934
Additional paid-in-capital		5,245,612			5,125,558
Accumulated deficit		(24,678,248	)		(24,377,514	)
Total Stockholders' Equity		1,408,490			1,589,170

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	2,358,016		$	2,892,487

The accompanying notes are an integral part of these financial statements.

F-1

Table of Contents

OPTIMIZERx CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE MONTHS ENDED MARCH 31, 2012 AND 2011

	For the three			For the three
	months ended			months ended
	March 31,			March 31,
	2012			2011
				(Restated)
REVENUE
Sales	$	329,403		$	393,843

TOTAL REVENUE		329,403			393,843

EXPENSES
Operating expenses		630,322			634,281

TOTAL EXPENSES		630,322			634,281

LOSS FROM OPERATIONS		(300,919	)		(240,438	)

OTHER INCOME (EXPENSE)
Interest income		185			440
Other income		-0-			66
Interest expense		-0-			(140,000	)

TOTAL OTHER INCOME (EXPENSE)		185			(139,494	)

LOSS BEFORE PROVISION FOR INCOME TAXES		(300,734	)		(379,932	)

PROVISION FOR INCOME TAXES		-0-			-0-

NET LOSS	$	(300,734	)	$	(379,932	)

WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING: BASIC AND DILUTED		14,192,496			13,628,067

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.02	)	$	(0.03	)

The accompanying notes are an integral part of these financial statements.

F-2

Table of Contents

OPTIMIZERx CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE THREE MONTHS ENDED MARCH 31, 2012 AND 2011

	For the three			For the three
	months ended			months ended
	March 31,			March 31,
	2012			2011
				(Restated)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$	(300,734	)	$	(379,932	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization		46,023			30,050
Stock-based compensation		120,054			-0-
Amortization of debt discount		-0-			125,000
Changes in:
Accounts receivable		355,412			(112,911	)
Prepaid expenses		5,033			61,467
Accounts payable		(159,640	)		210,735
Accrued interest		-0-			15,000
Accrued expenses		(66,700	)		9,300
Deferred revenue		(127,452	)		(50,270	)
NET CASH USED BY OPERATING ACTIVITIES		(128,004	)		(91,561	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(1,424	)		-0-
Website site development costs		(32,235	)		(37,610	)
NET CASH USED BY INVESTING ACTIVITIES		(33,659	)		(37,610	)

NET (DECREASE) IN CASH AND CASH EQUIVALENTS		(161,663	)		(129,171	)

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD		959,166			1,278,094

CASH AND CASH EQUIVALENTS - END OF PERIOD	$	797,503		$	1,148,923

SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	$	-0-		$	-0-
Cash paid for income taxes	$	-0-		$	-0-
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued to satisfy dividends related to preferred stock	$	-0-		$	250,000

The accompanying notes are an integral part of these financial statements.

F-3

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 1 – NATURE OF BUSINESS

Optimizer Systems, LLC was formed in the State of Michigan on January 31, 2006. It then became a corporation in the State of Michigan on October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April 30, 2008, RFID’s officers and directors resigned their positions and RFID changed its business to OptimizeRx’s business. On April 15, 2008, RFID, Ltd.’s corporate name was changed to OptimizeRx Corporation. On September 4, 2008, a migratory merger was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").

The wholly-owned subsidiary, OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Their objective is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology. Once defined as a marketing and advertising company through its consumer website, OptimizeRx is maturing as a technology solutions provider as it launched its direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution can either sit on the doctor’s desktop or can be integrated into the ePrescribing or Electronic Medical Records applications. OptimizeRx solutions provide pharmaceutical manufacturers either a direct to consumer and/or direct to physician channels for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability to the patients.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with the SEC as of and for the year ended December 31, 2011. In the opinion of management, all adjustments necessary for the financial statements to be not misleading for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Accounting Basis

The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

Principles of Consolidation

The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.

F-4

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.

Cash and Cash Equivalents

For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.

Fair Value of Financial Instruments

The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable – related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature. The fair value of long-term debt, which approximates its carrying value, is based on current rates at which the Company could borrow funds with similar remaining maturities.

Property and Equipment

The capital assets are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for book purposes.

Revenue Recognition

All revenue is recognized when it is earned. Revenues are generated either through the Company’s website activities, in which we earn revenue from advertising and lead generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons, and vouchers that enable our customers to save money on medical products and services. The Company’s processes are monitored by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Company’s account.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

Research and Development

The Company’s key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.

The Company seeks to educate team members through understanding of all market dynamics that have the potential to affect the business both short term and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through technology, better user experiences and new ways to engage industries to provide new support for patients needing their products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide robust opportunities and growth during the next five years.

F-5

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Concentration of Credit Risks

The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.

Earnings Per Common and Common Equivalent Share

The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents are not included in the diluted earnings per share calculation for March 31, 2012 and 2011, respectively, since their effect is anti-dilutive.

Impairment of Long-Lived Assets

The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Recently Issued Accounting Guidance

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

NOTE 3 – PREPAID EXPENSES

Prepaid expenses consisted of the following as of March 31, 2012 and December 31, 2011:

	2012		2011
Insurance	$	5,147	$	5,937
Website maintenance		8,750		17,500
Rent		5,049		0
Consulting		84,318		91,811
Employee advances		7,646		694
Advertising		3,090		3,090
Total prepaid expenses	$	114,000	$	119,032

F-6

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 4 – PROPERTY AND EQUIPMENT

The Company owned equipment recorded at cost which consisted of the following as of March 31, 2012 and December 31, 2011:

	2012			2011
Computer equipment	$	21,554		$	20,130
Furniture and fixtures		11,088			11,088
Subtotal		32,642			31,218
Accumulated depreciation		(8,587	)		(7,287	)
Property and equipment, net	$	24,055		$	23,931

Depreciation expense was $1,300 and $452 for the three months ended March 31, 2012 and 2011, respectively.

NOTE 5 – WEBSITE DEVELOPMENT COSTS

The Company has capitalized costs in developing their website and web-based products, which consisted of the following as of March 31, 2012 and December 31, 2011:

	2012			2011
OptimizeRx web development	$	154,133		$	154,133
SampleMD web development		586,112			553,877
Subtotal, web development costs		740,245			708,010
Accumulated amortization		(214,476	)		(183,429	)
Impairment		(59,083	)		(59,083	)
Web development costs, net	$	466,686		$	465,498

The Company began amortizing the OptimizeRx website costs, using the straight-line method over the estimated useful life of 5 years, once it was put into service in December of 2007. During the year ended December 31, 2009, the Company began a new web-based project and the related programming and development costs have been capitalized for the SampleMD website. The project was completed in mid-December 2010 and no amortization was recorded in 2010. Amortization began on the straight-line method in January 2011 over the period of five years. Although the Project was completed in mid-December, the Company continues to enhance and upgrade the website. Monthly payments for these upgrades and enhancements have been capitalized and amortization was started by quarter in 2011 and continues in 2012. The Company determined that the original OptimizeRx website was no longer useful so the remaining unamortized balance of $59,083 was impaired as of December 31, 2010.

Amortization expense was $31,047 and $15,920 for the three months ended March 31, 2012 and 2011, respectively.

NOTE 6 – PATENT RIGHTS AND INTANGIBLE ASSETS

On April 26, 2010, the Company acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.

F-7

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 6 – PATENT RIGHTS AND INTANGIBLE ASSETS (CONTINUED)

The Company has capitalized costs in purchasing the SampleMD patent, which consisted of the following as of March 31, 2012 and December 31, 2011:

	2012			2011
Patent rights and intangible assets	$	930,000		$	930,000
Accumulated amortization		(95,735	)		(82,059	)
Patent rights and intangible assets, net	$	834,265		$	847,941

The Company began amortizing the patent, using the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. Amortization expense was $13,676 and $13,677 for the three months ended March 31, 2012 and 2011, respectively.

NOTE 7 – ACCRUED EXPENSES

Accrued expenses consisted of the following as of March 31, 2012 and December 31, 2011:

	2012		2011
Accrued payroll taxes	$	322	$	0
Accrued bonuses		0		60,000
Accrued audit fees		0		6,000
Total accrued expenses	$	322	$	66,000

NOTE 8 – DEFERRED REVENUE

The Company has signed several contracts with customers for coupon redemptions on their website. The payments are not taken into revenue until the end user redeems the coupon. The redemptions are tracked via their website and revenues are recorded as the coupons are redeemed. Additionally, customer setup contracts that have been paid in full are deferred until the Company has completed the obligations of the contacts. Deferred revenue was $203,153 and $330,605 as of March 31, 2012 and December 31, 2011, respectively.

NOTE 9 – NOTE PAYABLE

On October 5, 2010, the Company issued a secured promissory note of $1,000,000 to an investor. The note accrues interest at 6% per annum, compounded on April and October each year and will be paid at the earliest of September 12, 2012 or earlier at the Company’s option. No principal or interest payments are required until the maturity date. Accrued interest was $15,000 as of December 31, 2010. The terms of the note also granted 1,000,000 stock warrants and 1,000,000 contingent stock warrants in connection with the financing. The non-contingent warrants were valued at $1,007,992 with $1,000,000 recorded as debt discount and $7,992 recorded as interest expense in the December 31, 2010 year. The Company analyzed the assumptions associated with the contingent warrants and determined that the performance objectives were not likely to occur in 2011. Therefore, no value was recorded for the contingent warrants. The debt discount derived from the warrant valuation of $1,000,000 was being amortized over the life of the loan using the straight-line method and charged to interest expense.

On September 16, 2011, the Company entered into a Termination Agreement, in conjunction with a Securities Purchase Agreement with another investor. Under the Termination Agreement, the Company paid off the $1,000,000 promissory note, plus all accrued interest to date. Upon payment of the note, the contingent stock warrants obligation was terminated and the remaining debt discount from the warrant valuation was expensed. See Note 12.

F-8

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 10 – COMMON STOCK

OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of March 31, 2012.

There were 14,192,496 common shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively.

On June 30, 2011, the Company entered into a settlement agreement with Midtown Partners. Under the settlement agreement, the Company will pay Midtown Partners $57,500 and grant 100,000 shares of its common stock. The cost of the settlement has been recorded as equity issuance costs. As a result of the settlement, the litigation in the Eastern District of Michigan was dismissed.

During the year ended December 31, 2011, the Company issued 475,820 shares of common stock to satisfy $500,000 of preferred dividends.

NOTE 11 – PREFERRED STOCK

Series A Preferred

During the year ended December 31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.

The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management’s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion price.

The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.

On May 12, 2010, the Company’s Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November 16, 2010, the Company’s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March 25, 2011, the Company’s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment.

F-9

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 11 – PREFERRED STOCK (CONTINUED)

Series B Preferred

During the year ended December 31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 2,000,000 shares of common stock at an exercise price of $3 for a period of seven years.

The preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were allocated to the preferred stock.

During the quarter ended September 30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 12.

The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management’s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1.50 conversion price.

The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. On March 25, 2011, the Company’s Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment.

NOTE 12 – STOCK OPTIONS AND WARRANTS

The Company accounts for employee stock-based compensation in accordance with the guidance of ASC Topic 718: Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.

F-10

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 12 – STOCK OPTIONS AND WARRANTS (CONTINUED)

The Company follows ASC Topic 505-50, formerly EITF 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods and Services,” for stock options and warrants issued to consultants and other non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered.

On October 1, 2010, the Company issued 25,000 stock options to an employee with a vesting period of one year and an exercise price of $1.21. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 241%, risk-free interest rate of 1.26% and expected life of 60 months. The Company recognized share-based compensation expense of $6,203 during the year ended December 31, 2010 with the remaining balance of $18,610 to be recognized in 2011. $6,203 has been recognized in the year ended September December 31, 2011.

On April 27, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 221%, risk-free interest rate of 2.06% and expected life of 60 months. The agreement is for a period of six months. The Company recognized expenses of $83,992 during the year ended December 31, 2011.

On May 31, 2011, the Company issued 285,000 stock options to 3 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 218%, risk-free interest rate of 1.68% and expected life of 60 months. The total value of the options was $320,585. The options vest over one year. The Company recognized share-based compensation expense of $187,005 during the year ended December 31, 2011. The remaining balance will be recognized over the following five months of 2012.

During the quarter ended September 30, 2011, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. In addition, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 11.

During the quarter ended December 31, 2011, the Company issued 20,000 stock options to 2 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 204-205%, risk-free interest rate of 0.88-0.93% and expected life of 60 months. The total value of the options was $19,270. The options vest over one year. The Company recognized share-based compensation expense of $2,480 during the year ended December 31, 2011 and $4,818 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.

F-11

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 12 – STOCK OPTIONS AND WARRANTS (CONTINUED)

On November 21, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 205%, risk-free interest rate of 0.92% and expected life of 60 months. The Company recognized expenses of $8,346 during the year ended December 31, 2011 and $25,039 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.

During the quarter ended March 31, 2012, the Company issued 50,000 stock options to 4 non-employees at an exercise price of $0.89. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 198%, risk-free interest rate of 0.65% and expected life of 48 months. The total value of the options was $35,091. The options vest over 4 months. The Company recognized share-based compensation expense of $17,546 during the quarter ended March 31, 2012. The remaining balance has been recorded as a prepaid expense and will be recognized over the following quarter.

NOTE 13 – OPERATING LEASES

The Company signed a lease for new office space on December 1, 2011 at an approximate rent of $5,000 per month. The new offices are in Rochester, Michigan. The lease is for three years with an option to renew for an additional two years at approximately $5,200 per month with six months advance notice to exercise the option.

Minimum annual rent is as follows for the initial term of the lease:

Year ended December 31, 2012	$	60,591
2013		60,591
2014		55,542
2015		0
Total lease commitment	$	176,724

NOTE 14 – RELATED PARTY TRANSACTIONS

During the year ended December 31, 2010, the Company acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.

NOTE 15 – MAJOR CUSTOMERS

The Company had four major customers that accounted for 74% and two major customers that accounted for 76% of the Company’s revenues for the three months ended March 31, 2012 and 2011, respectively. The Company expects to continue to maintain these relationships with the customers.

F-12

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 16 – INCOME TAXES

For the three months ended March 31, 2012, the Company incurred a net loss of approximately $301,000 and therefore has no tax liability. The Company began operations in 2007 and has previous net operating loss carry-forwards of $13,479,000 through December 31, 2011. The cumulative loss of $13,780,000 will be carried forward and can be used through the year 2032 to offset future taxable income. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.

The provision for Federal income tax consists of the following for the three months ended March 31, 2012 and 2011:

	2012			2011
Federal income tax benefit attributable to:
Current operations	$	102,000		$	129,000
Valuation allowance		(102,000	)		(129,000	)
Net provision for federal income tax	$	0		$	0

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of March 31, 2012 and December 31, 2011:

	2012			2011
Deferred tax asset attributable to:
Net operating loss carryover	$	4,685,000		$	4,583,000
Valuation allowance		(4,685,000	)		(4,583,000	)
Net deferred tax asset	$	0		$	0

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $13,780,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

NOTE 17 – OPERATING EXPENSES

Operating expenses consisted of the following for the three months ended March 31, 2012 and 2011, respectively:

	2012		2011 (restated)
Advertising	$	11,270	$	187,265
Professional fees		38,003		106,214
Consulting		6,615		46,775
Salaries, wages and benefits		306,895		173,714
Rent		16,918		7,500
Depreciation and amortization		46,023		30,050
Stock-based compensation		127,548		0
General and administrative		77,050		82,763
Total Operating Expenses	$	630,322	$	634,281

F-13

Table of Contents

OPTIMIZERx CORPORATION

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2012

NOTE 18 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has sustained substantial losses since inception.

In view of this matter, the ability of the Company to continue as a going concern is dependent upon growth of revenues and the ability of the Company to raise additional capital. Management believes that its successful ability to raise capital and increases in revenues will provide the opportunity for the Company to continue as a going concern.

NOTE 19 – RESTATEMENT

The Company has restated its Consolidated Statement of Operations and its Consolidated Statement of Cash Flows for the three months ended March 31, 2011 to correct an error in its accounting. The Company did not originally accrue expenses related to advertising, marketing and employee bonuses during that period.

		Three months ended March 31, 2011
Financial Statement	Line Item	Corrected	Previously Stated
Income statement	Operating expenses	634,281	469,281
Income statement	Loss from operations	(240,438)	(75,438)
Income statement	Loss before provision for income taxes	(379,932)	(214,932)
Income statement	Net loss	(379,932)	(214,932)
Statement of cash flows	Net loss	(379,932)	(214,932)
Statement of cash flows	Change in accounts payable	210,735	60,735
Statement of cash flows	Change in accrued expenses	9,300	(5,000)
Statement of cash flows	Change in payroll taxes payable	0	(700)

NOTE 20 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to March 31, 2012 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

F-14

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

Overview

Throughout industry and economic discussions we often hear the catch phrase, “The Perfect Storm,” but none is as prevalent as the transitional business climate between healthcare providers and pharmaceutical manufacturers. The year 2011 has seen greater pressures on health care providers to increase both the volume and value of the services they provide to their patients—with fewer resources.

This cumulates with their high focus and scrutiny of ways to reduce their drug costs, primarily through decreased utilization of branded medications when a generic alternative is available. To do this, health systems have restricted pharmaceutical manufacturers’ access to their doctors and no longer accepting drug samples, along with passing more of the cost of branded medication to patients through increased co-pays. Through electronic prescribing (ePrescribing), health systems now have a way of informing physicians of the coverage differential every time they look up a medication to prescribe. ePrescribing now represents over 450 million prescription that are sent directly to pharmacies and is projected to grow to 2 billion by 2016 due to government incentives and rapid adaption.

Table of Contents

In turn, these increased pressures and the lack of access pharmaceutical representatives have to doctors have left pharmaceutical manufacturers in need of a new solutions to bridge the gap in promoting their drugs value. Additionally, they’re co-pay and sample vouchers, which increase the likelihood that a patient can better afford to start and stay on their medications, has been difficult to distribute to the doctors and patients needing their help.

Thus, OptimizeRx Corp., through its SampleMD™ electronic patient savings and support technology, is poised to provide great impact to each stakeholder by automatically added a savings eCoupon and patient support right within the electronic prescription process.

For OPTIMIZERx, 2011 continued to be a centered on completing and commercializing our SampleMD™ solution. Early beta testing within targeted healthcare systems provided both a test bed and focus group feedback on utilization and user interface requirements. Additionally, the early roll out of the SampleMD™ engine integrated within the Allscripts, the world’s largest ePrescribing application, showed early signs of great potential, but also exposed some hurdles that needed to be cleared to seamlessly streamline the physician’s workflow and ensure all transactional information is captured. Overall, for both installed applications, desk top and ePrescribing, clinicians were satisfied with the ease and availability of the SampleMD™ solution.

Incorporating the feedback and results we compiled from these early test environments, OPTIMIZERx rolled out our SampleMD™ version 3.0 in the 4th quarter 2011 that featured enhanced access to formulary information, a broader search capability and the introduction of our eRep Scheduler, a tool for clinicians and pharmaceutical representatives to establish a rules-based appointment scheduler to set fixed appointments. OPTIMIZERx also continued to optimize the integration between the SampleMD™ solution and multiple ePrescribing and Electronic Medical Record providers. The Allscripts ePrescribing integration continues to show increasing results and clinician adoption while we began integration of our new partner NewCrop. NewCrop is an industry leading electronic prescribing service that has been deployed in over 150 Electronic Medical Record providers and medical networks since 2003.

We also have signed contracts with other ePrescribing platforms that have the potential to triple our reach to over 100,000 physicians in 2012. This clearly position us as the market leader in offering physicians a way to automatically add and electronically distribute co-pay coupons, sample vouchers and patient education to their patients. Likewise, we are uniquely able to offer pharmaceutical manufacturers one platform to manage, promote and report their patient support to physicians- right within their current workflow.

In our 3rd and fourth quarter of 2011, we secured additional financing to support our continued growth and the recognized need for additional resources within the technical, sales and administrative disciplines. We used $1,056,876 to pay back the note to Physicians Interactive, with the balance of the funds allocated to be used to support the acquisition of additional resources needed to support our growth.

Table of Contents

In addition to hiring a new Vice President of Eastern Sales we increased our Sales/Marketing staff to assist with supporting the sales organization and begin to build out and coordinate our brand marketing and awareness programs. We have focused on driving our market message and gained significant exposure while participating in the Allscripts User Conference in August of 2011. With some 3500 plus attendees, we gained valuable exposure to health systems and pharmaceutical manufacturers. Additionally, we participated within the HIMMS health care technology conference, the Marcus Evan Executive Marketing roundtable and launched an Ad campaign surrounding our SampleMD™ solution and its benefits to the health care provider advertising in Pharmaceutical Executive Magazine. We also initiated a number of email marketing campaigns as well as initiating a SampleMD™ newsletter. It is our intent to continue to drive market awareness, secure additional sales, align with additional channel partners, and to acquire the necessary resources to support our continued growth.

As we settled into our new office location at 400 Water Street, Suite 200, Rochester, MI 48307, for the first quarter of 2012, we generated revenue post launch of the SampleMD initiative of $329,403. We continued our development course with efforts to complete the integration of the SampleMD solution within the NewCrop ePrescribing application and begin integration within the DrFirst ePrescribing platform, all that supports more than 150 EMR’s, and broadens our channel reach to some 100,000 plus participating doctors and clinicians.

We continued to update our eRep scheduler while it ran a beta / focus group within a major health care provider. We continue to enhance and refine our base eRep scheduler while further expanding the technology connections between the pharmaceutical manufacturers and the health care providers.

We continue to promote our SampleMD solution as we are preparing to participate at the Marcus Evens Pharma Executive Summit and the Health Connect Partners events early in the 2^nd quarter of 2012. Additionally, first quarter sales activity continued to focus on contract renewals as well as acquiring new opportunities.

Results of Operations for the Three Months Ended March 31, 2012 and 2011

Revenues

Our total revenue reported for the three months ended March 31, 2012 was $329,403, a decrease from $393,843 from the prior year period.

Our decreased revenue for the three months ended March 31, 2012 as compared with the prior year period is a result of delays in receiving our contract renewals in a timely basis from our existing clients. Additionally, we continue to bring on new programs in replacement of some brands which have gone off brand and are now generic and continue to secure new programs and brand participation.

Table of Contents

Operating Expenses

Operating expenses decreased to $630,322 for the three months ended March 31, 2012 from $634,281 for the three months ended March 31, 2011. Our major expenses for the three months ended March 31, 2012 were sales, wages and benefits of $306,895, stock-based compensation of $127,548, and general and administrative expenses of $77,050. In comparison, our major expenses for the three months ended March 31, 2011 were advertising of $187,265, salaries, wages and benefits of $173,714, professional fees of $106,214 and general and administrative expenses of $82,763.

Other Income/Expenses

Other income was $185 for three months ended March 31, 2012 an increase from other expenses of $139,494 for same period ended 2011. We had no interest expenses in 2012 with $140,000 in 2011, which mostly accounted for the difference between the periods.

Net Loss

Net loss for the three months ended March 31, 2012 was $300,734, compared to net loss of $ $379,932 for the three months ended March 31, 2011.

Liquidity and Capital Resources

As of March 31, 2012, we had total current assets of $1,027,961 and total assets in the amount of $2,358,016. Our total current liabilities as of March 31, 2012 were $949,526. We had working capital of $78,435 as of March 31, 2012.

Operating activities used $128,004 in cash for the three months ended March 31, 2012. Our net loss of $300,734 along with $159,640 in accounts payable and $127,452 in deferred revenue were the primary component of our negative operating cash flow, offset mainly by $355,412 in accounts receivable. Investing activities used $33,659 during the three months ended March 31, 2012 largely as a result of website development costs.

On September 16, 2011, we entered into a Securities Purchase Agreement with Vicis for sale of up to 50 shares of our Series B Preferred Stock and warrants to purchase up to 3,333,334 shares of our common stock with an exercise price of $3.00 per share (the “Vicis Warrants”).

We already sold 15 shares of Series B Preferred Stock and a warrant to purchase 1,000,000 shares of our common stock at the above exercise price for $1,500,000. This money was used to pay off a promissory note we had with Physicians Interactive and the balance is for working capital.

Thereafter, a subsequent closing may occur at our option commencing on December 1, 2011 for the sale of an additional 15 shares of Series B Preferred Stock and a warrant to purchase an additional 1,000,000 shares of our common stock for $1,500,000. A final subsequent closing may occur at our option commencing on May 1, 2012 for the sale of an additional 20 shares of Series B Preferred Stock and a warrant to purchase an additional 1,333,334 shares of our common stock for $2,000,000.

Table of Contents

Each share of Series B Preferred Stock is convertible at the option of the holder into that number of shares of our common stock equal to the Stated Value ($100,000) divided by a per share price of the common stock of $1.50 per share (the “Conversion Price”). A holder may effect a conversion at any time after the earlier of (a) the time that the Securities and Exchange Commission declares effective a registration statement registering the shares of common stock to be sold by the holder that underlie the shares of Series B Preferred Stock held by such holder (the “Conversion Shares’) and (b) the time such Conversion Shares are eligible for resale by the holder pursuant to Rule 144 of the Securities Act of 1933, as amended, (the “Conversion Eligibility Date”).

If after the Conversion Eligibility Date the market price for the common stock for any ten consecutive trading days exceeds $2.00 (subject to adjustment for reverse and forward stock splits, stock combinations and other similar transactions of the common stock that may occur) and the average daily trading volume for the common stock during such ten day period exceeds 100,000 shares (such period, the “Threshold Period”), the Company may, at any time after the fifth trading day after the end of any such period, deliver a notice to the holder (a “Forced Conversion Notice” and the date such notice is received by the holder, the “Forced Conversion Notice Date”) to cause the holder to immediately convert all and not less than all of the Stated Value of the shares held by such Holder plus accumulated and unpaid dividends at the then current Conversion Price (a “Forced Conversion”). We may only effect a Forced Conversion Notice if all of the conditions specified in the purchase agreement are met through the applicable Threshold Period until the date of the applicable Forced Conversion and through and including the date such shares of common stock are issued to the holder.

The Vicis Warrants are exercisable for a period of seven years at an exercise price of $3.00 per share. The Vicis Warrants are also exercisable on a cashless basis. In addition, the Vicis Warrants are subject to anti-dilution adjustments and protections in the event of stock splits and stock dividends, subsequent equity sales entitling persons to acquire shares of common stock at an effective price per share that is lower than the then exercise price of the warrants and subsequent rights offerings, in the event we issue rights, options or warrant to all holders of common stock and not to the warrant holders, pro rata distributions of assets or indebtedness and fundamental transactions, such as a merger, consolidation or recapitalization. The anti-dilution adjustment shall apply the lowest sale price as being the adjusted option price or conversion ratio for existing shareholders.

As of March 31, 2012 with the current level of financing and cash on hand, we have sufficient cash to operate our business at the current level for the next twelve months but insufficient cash to achieve our business goals unless we: a) realize cash revenues on sales generated; b) continue with the sale of our Series B Preferred Stock to Vicis; and/or c) obtain additional financing through debt and/or equity based financing arrangements which may be insufficient to fund our capital expenditures, working capital, or other cash requirements. There can be no assurance that such additional financing will be available to us on acceptable terms, or at all.

Table of Contents

Off Balance Sheet Arrangements

As of March 31, 2012, there were no off balance sheet arrangements.

Going Concern

The accompanying financial statements have been prepared assuming that we will continue as a going concern. We have sustained substantial losses since inception.

In view of this matter, our ability to continue as a going concern is dependent upon growth of revenues and our ability to raise additional capital. Management believes that our successful ability to raise capital and increases in revenues will provide us the opportunity to continue as a going concern.

Critical Accounting Policies

In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Our critical accounting policies are set forth in Note 2 to the financial statements.

Recently Issued Accounting Pronouncements

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operation, financial position or cash flow.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

A smaller reporting company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of March 31, 2012. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, Mr. David Lester. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2012, our disclosure controls and procedures are effective. There have been no significant changes in our internal controls over financial reporting during the quarter ended March 31, 2012 that have materially affected or are reasonably likely to materially affect such controls.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Limitations on the Effectiveness of Internal Controls

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the internal control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 1A: Risk Factors

A smaller reporting company is not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the current reporting period, we issued the following securities:

During the current reporting period, we entered into an agreement with an investment relations company and in connection with that agreement we issued four-year cashless warrants to purchase 50,000 shares of our common stock at an exercise price of 120% of the closing price on the date of issuance.

These issuances were deemed to be exempt under rule 506 of Regulation D and Section 4(2) of the Securities Act of 1933, as amended, since, among other things, the transactions did not involve a public offering, the investors were accredited investors and / or qualified institutional buyers, the investors had access to information about the Company and their investment, the investors took the securities for investment and not resale, and the Company took appropriate measures to restrict the transfer of the securities.

Item 3. Defaults upon Senior Securities

None

Item 4. Mine Safety Disclosure

Item 5. Other Information

None

Item 6. Exhibits

Exhibit Number	Description of Exhibit
10.1	Settlement Agreement, dated June 30, 2011⁽¹⁾
31.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(1) Incorporated by reference to the quarterly report on Form 10-Q filed on November 14, 2011.

Table of Contents

SIGNATURES

In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	OptimizeRx Corporation

Date:	May 15, 2012

	By: s/ David Lester David Lester Title: Chief Executive Officer, Chief Financial Officer, and Director

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

CERTIFICATIONS

I, David Lester, certify that;

I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2012 of OptimizeRx Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ David Lester

By: David Lester

Title: Chief Executive Officer

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

CERTIFICATIONS

I, David Lester, certify that;

I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2012 of OptimizeRx Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ David Lester

By: David Lester

Title: Chief Financial Officer

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly Report of OptimizeRx Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2012 filed with the Securities and Exchange Commission (the “Report”), I, David Lester, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

By:	/s/ David Lester
Name:	David Lester
Title:	Principal Executive Officer, Principal Financial Officer and Director
Date:	May 15, 2012

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

EX-101.INS 5 oprx-20120331.xml XBRL INSTANCE FILE 0001448431 2012-01-01 2012-03-31 0001448431 2012-03-31 0001448431 2011-12-31 0001448431 2011-01-01 2011-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares OptimizeRx Corp 0001448431 10-Q 2012-03-31 false --12-31 No No No Smaller Reporting Company Q1 2012 14192496

-300734

-379932

46023

30050

125000

355412

-112911

5033

61467

-159640

210735

15000

-66700

9300

-127452

-50270

-128004

-91561

-1424

-32235

-37610

-33659

-37610

959166 1278094 797503 1148923

250000

797503

959166

116458

471870

114000

119032

1027961

1550068

24055

23931

834265

847941

466686

465498

1306000

1318488

2358016

2892487

176051

336712

570000

322

66000

203153

330605

949526

1303317

14192

20826934

5245612

5125558

-24678248

-24377514

1408490

1589170

2358016

2892487

329403

393843

329403

393843

630322

634281

630322 634281

185

440

-140000

185

-139494

-300734 -379932

-300734

-379932

14192496

13628067

-0.02

-0.03

0.001

.001

500000000

14192496

0.001

10000000

5049

-300919

-240438

-161663

-129171

120054

Optimizer Systems, LLC was formed in the State of Michigan on January 31, 2006. It then became a corporation in the State of Michigan on October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April 30, 2008, RFIDs officers and directors resigned their positions and RFID changed its business to OptimizeRxs business. On April 15, 2008, RFID, Ltd.s corporate name was changed to OptimizeRx Corporation. On September 4, 2008, a migratory merger was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").   The wholly-owned subsidiary, OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Their objective is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology. Once defined as a marketing and advertising company through its consumer website, OptimizeRx is maturing as a technology solutions provider as it launched its direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution can either sit on the doctors desktop or can be integrated into the ePrescribing or Electronic Medical Records applications. OptimizeRx solutions provide pharmaceutical manufacturers either a direct to consumer and/or direct to physician channels for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability to the patients.

Basis of Presentation The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (SEC), and should be read in conjunction with the audited financial statements and notes thereto contained in the Companys Form 10-K filed with the SEC as of and for the year ended December 31, 2011.  In the opinion of management, all adjustments necessary for the financial statements to be not misleading for the interim periods presented have been reflected herein.  The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.   Accounting Basis The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (GAAP accounting). The Company has adopted a December 31 fiscal year end.   Principles of Consolidation The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.   Reclassifications Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.   Cash and Cash Equivalents For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.   Fair Value of Financial Instruments The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature. The fair value of long-term debt, which approximates its carrying value, is based on current rates at which the Company could borrow funds with similar remaining maturities.   Property and Equipment The capital assets are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for book purposes.   Revenue Recognition All revenue is recognized when it is earned. Revenues are generated either through the Companys website activities, in which we earn revenue from advertising and lead generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons, and vouchers that enable our customers to save money on medical products and services. The Companys processes are monitored by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Companys account.   Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.   Research and Development The Companys key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.   The Company seeks to educate team members through understanding of all market dynamics that have the potential to affect the business both short term and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through technology, better user experiences and new ways to engage industries to provide new support for patients needing their products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide robust opportunities and growth during the next five years.   Concentration of Credit Risks The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.   Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.   Earnings Per Common and Common Equivalent Share The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents are not included in the diluted earnings per share calculation for March 31, 2012 and 2011, respectively, since their effect is anti-dilutive.   Impairment of Long-Lived Assets The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.   Recently Issued Accounting Guidance The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Companys results of operations, financial position or cash flow.

Prepaid expenses consisted of the following as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt; width: 54%">Insurance</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">5,147</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">5,937</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Website maintenance</td> <td style="text-align: left"> </td> <td style="text-align: right">8,750</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">17,500</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt">Rent</td> <td style="text-align: left"> </td> <td style="text-align: right">5,049</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="padding-left: 5.4pt">Consulting</td> <td style="text-align: left"> </td> <td style="text-align: right">84,318</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">91,811</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Employee advances</td> <td style="text-align: left"> </td> <td style="text-align: right">7,646</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">694</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Advertising</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">3,090</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">3,090</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total prepaid expenses</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">114,000</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">119,032</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>

The Company owned equipment recorded at cost which consisted of the following as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt; width: 54%">Computer equipment</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">21,554</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">20,130</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Furniture and fixtures</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">11,088</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">11,088</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt">    Subtotal</td> <td style="text-align: left"> </td> <td style="text-align: right">32,642</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">31,218</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated depreciation</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(8,587</td> <td style="text-align: left; padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,287</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">   Property and equipment, net</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">24,055</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">23,931</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   Depreciation expense was $1,300 and $452 for the three months ended March 31, 2012 and 2011, respectively.

The Company has capitalized costs in developing their website and web-based products, which consisted of the following as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt; width: 54%">OptimizeRx web development</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">154,133</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">154,133</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">SampleMD web development</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">586,112</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">553,877</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">   Subtotal, web development costs</td> <td style="text-align: left"> </td> <td style="text-align: right">740,245</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">708,010</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Accumulated amortization</td> <td style="text-align: left"> </td> <td style="text-align: right">(214,476</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(183,429</td> <td style="text-align: left">)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Impairment</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(59,083</td> <td style="text-align: left; padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(59,083</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">   Web development costs, net</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">466,686</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">465,498</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   The Company began amortizing the OptimizeRx website costs, using the straight-line method over the estimated useful life of 5 years, once it was put into service in December of 2007. During the year ended December 31, 2009, the Company began a new web-based project and the related programming and development costs have been capitalized for the SampleMD website. The project was completed in mid-December 2010 and no amortization was recorded in 2010. Amortization began on the straight-line method in January 2011 over the period of five years. Although the Project was completed in mid-December, the Company continues to enhance and upgrade the website. Monthly payments for these upgrades and enhancements have been capitalized and amortization was started by quarter in 2011 and continues in 2012. The Company determined that the original OptimizeRx website was no longer useful so the remaining unamortized balance of $59,083 was impaired as of December 31, 2010.   Amortization expense was $31,047 and $15,920 for the three months ended March 31, 2012 and 2011, respectively. Accrued expenses consisted of the following as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt; width: 54%">Accrued payroll taxes</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">322</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">0</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Accrued bonuses</td> <td style="text-align: left"> </td> <td style="text-align: right">0</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">60,000</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accrued audit fees</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">0</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">6,000</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"> Total accrued expenses</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">322</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">66,000</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>

The Company has signed several contracts with customers for coupon redemptions on their website. The payments are not taken into revenue until the end user redeems the coupon. The redemptions are tracked via their website and revenues are recorded as the coupons are redeemed. Additionally, customer setup contracts that have been paid in full are deferred until the Company has completed the obligations of the contacts. Deferred revenue was $203,153 and $330,605 as of March 31, 2012 and December 31, 2011, respectively.

OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of March 31, 2012.   There were 14,192,496 common shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively.   On June 30, 2011, the Company entered into a settlement agreement with Midtown Partners.  Under the settlement agreement, the Company will pay Midtown Partners $57,500 and grant 100,000 shares of its common stock.  The cost of the settlement has been recorded as equity issuance costs. As a result of the settlement, the litigation in the Eastern District of Michigan was dismissed.    During the year ended December 31, 2011, the Company issued 475,820 shares of common stock to satisfy $500,000 of preferred dividends.

Series A Preferred   During the year ended December 31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.   The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at managements discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion price.   The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.   On May 12, 2010, the Companys Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November 16, 2010, the Companys Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March 25, 2011, the Companys Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment.   Series B Preferred   During the year ended December 31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 2,000,000 shares of common stock at an exercise price of $3 for a period of seven years.   The preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were allocated to the preferred stock.   During the quarter ended September 30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 12.   The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at managements discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1.50 conversion price.   The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. On March 25, 2011, the Companys Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment.

The Company accounts for employee stock-based compensation in accordance with the guidance of ASC Topic 718: Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.    The Company follows ASC Topic 505-50, formerly EITF 96-18, Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods and Services, for stock options and warrants issued to consultants and other non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered.   On October 1, 2010, the Company issued 25,000 stock options to an employee with a vesting period of one year and an exercise price of $1.21. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 241%, risk-free interest rate of 1.26% and expected life of 60 months. The Company recognized share-based compensation expense of $6,203 during the year ended December 31, 2010 with the remaining balance of $18,610 to be recognized in 2011. $6,203 has been recognized in the year ended September December 31, 2011.   On April 27, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 221%, risk-free interest rate of 2.06% and expected life of 60 months. The agreement is for a period of six months. The Company recognized expenses of $83,992 during the year ended December 31, 2011.   On May 31, 2011, the Company issued 285,000 stock options to 3 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 218%, risk-free interest rate of 1.68% and expected life of 60 months. The total value of the options was $320,585. The options vest over one year. The Company recognized share-based compensation expense of $187,005 during the year ended December 31, 2011. The remaining balance will be recognized over the following five months of 2012.   During the quarter ended September 30, 2011, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. In addition, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 11.   During the quarter ended December 31, 2011, the Company issued 20,000 stock options to 2 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 204-205%, risk-free interest rate of 0.88-0.93% and expected life of 60 months. The total value of the options was $19,270. The options vest over one year. The Company recognized share-based compensation expense of $2,480 during the year ended December 31, 2011 and $4,818 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.    On November 21, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 205%, risk-free interest rate of 0.92% and expected life of 60 months. The Company recognized expenses of $8,346 during the year ended December 31, 2011 and $25,039 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.   During the quarter ended March 31, 2012, the Company issued 50,000 stock options to 4 non-employees at an exercise price of $0.89. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 198%, risk-free interest rate of 0.65% and expected life of 48 months. The total value of the options was $35,091. The options vest over 4 months. The Company recognized share-based compensation expense of $17,546 during the quarter ended March 31, 2012. The remaining balance has been recorded as a prepaid expense and will be recognized over the following quarter.

The Company signed a lease for new office space on December 1, 2011 at an approximate rent of $5,000 per month. The new offices are in Rochester, Michigan. The lease is for three years with an option to renew for an additional two years at approximately $5,200 per month with six months advance notice to exercise the option.   Minimum annual rent is as follows for the initial term of the lease:   <table cellspacing="0" cellpadding="0" style="width: 40%; border-collapse: collapse; font-size: 10pt"> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: right; width: 60%"> Year ended December 31, 2012</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 12%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 25%">60,591</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: right">2013</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">60,591</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: right">2014</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">55,542</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: right">2015</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">0</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: right">Total lease commitment</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">176,724</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>

Operating expenses consisted of the following for the three months ended March 31, 2012 and 2011, respectively:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011 (restated)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt; width: 54%">Advertising</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">11,270</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">187,265</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Professional fees</td> <td style="text-align: left"> </td> <td style="text-align: right">38,003</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">106,214</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt">Consulting</td> <td style="text-align: left"> </td> <td style="text-align: right">6,615</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">46,775</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Salaries, wages and benefits</td> <td style="text-align: left"> </td> <td style="text-align: right">306,895</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">173,714</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt">Rent</td> <td style="text-align: left"> </td> <td style="text-align: right">16,918</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,500</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and amortization</td> <td style="text-align: left"> </td> <td style="text-align: right">46,023</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">30,050</td> <td style="text-align: left"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="padding-left: 5.4pt">Stock-based compensation</td> <td style="text-align: left"> </td> <td style="text-align: right">127,548</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0</td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">General and administrative</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">77,050</td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">82,763</td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">   Total Operating Expenses</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">630,322</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">634,281</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> On October 5, 2010, the Company issued a secured promissory note of $1,000,000 to an investor. The note accrues interest at 6% per annum, compounded on April and October each year and will be paid at the earliest of September 12, 2012 or earlier at the Companys option. No principal or interest payments are required until the maturity date. Accrued interest was $15,000 as of December 31, 2010. The terms of the note also granted 1,000,000 stock warrants and 1,000,000 contingent stock warrants in connection with the financing. The non-contingent warrants were valued at $1,007,992 with $1,000,000 recorded as debt discount and $7,992 recorded as interest expense in the December 31, 2010 year. The Company analyzed the assumptions associated with the contingent warrants and determined that the performance objectives were not likely to occur in 2011. Therefore, no value was recorded for the contingent warrants. The debt discount derived from the warrant valuation of $1,000,000 was being amortized over the life of the loan using the straight-line method and charged to interest expense.   On September 16, 2011, the Company entered into a Termination Agreement, in conjunction with a Securities Purchase Agreement with another investor. Under the Termination Agreement, the Company paid off the $1,000,000 promissory note, plus all accrued interest to date. Upon payment of the note, the contingent stock warrants obligation was terminated and the remaining debt discount from the warrant valuation was expensed. See Note 12.

The Company had four major customers that accounted for 74% and two major customers that accounted for 76% of the Companys revenues for the three months ended March 31, 2012 and 2011, respectively. The Company expects to continue to maintain these relationships with the customers.

For the three months ended March 31, 2012, the Company incurred a net loss of approximately $301,000 and therefore has no tax liability. The Company began operations in 2007 and has previous net operating loss carry-forwards of $13,479,000 through December 31, 2011. The cumulative loss of $13,780,000 will be carried forward and can be used through the year 2032 to offset future taxable income. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.   The provision for Federal income tax consists of the following for the three months ended March 31, 2012 and 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left">Federal income tax benefit attributable to:</td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; width: 54%"> Current operations</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">102,000</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">129,000</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"> Valuation allowance</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(102,000</td> <td style="text-align: left; padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(129,000</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt">     Net provision for federal income tax</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">0</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">0</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left">Deferred tax asset attributable to:</td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; width: 54%"> Net operating loss carryover</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">4,685,000</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">4,583,000</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"> Valuation allowance</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(4,685,000</td> <td style="text-align: left; padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(4,583,000</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt">     Net deferred tax asset</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">0</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">0</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $13,780,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has sustained substantial losses since inception.   In view of this matter, the ability of the Company to continue as a going concern is dependent upon growth of revenues and the ability of the Company to raise additional capital. Management believes that its successful ability to raise capital and increases in revenues will provide the opportunity for the Company to continue as a going concern.

The Company has restated its Consolidated Statement of Operations and its Consolidated Statement of Cash Flows for the three months ended March 31, 2011 to correct an error in its accounting. The Company did not originally accrue expenses related to advertising, marketing and employee bonuses during that period.   <table cellspacing="0" cellpadding="0" style="width: 80%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"> </td> <td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Three months ended March 31, 2011</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 25%; padding-right: 5.4pt">Financial Statement</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 40%; padding-right: 5.4pt">Line Item</td> <td nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 15%; padding-right: 5.4pt">Corrected</td> <td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 20%; padding-right: 5.4pt">Previously Stated</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Income statement</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Operating expenses</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">634,281</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">469,281</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Income statement</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Loss from operations</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(240,438)</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(75,438)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Income statement</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Loss before provision for income taxes</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(379,932)</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(214,932)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Income statement</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Net loss</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(379,932)</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(214,932)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Statement of cash flows</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Net loss</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(379,932)</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(214,932)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Statement of cash flows</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Change in accounts payable</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">210,735</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">60,735</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Statement of cash flows</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Change in accrued expenses</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">9,300</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(5,000)</td></tr> <tr style="background-color: white; vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Statement of cash flows</td> <td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">Change in payroll taxes payable</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">0</td> <td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt">(700)</td></tr> </table>

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to March 31, 2012 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

On April 26, 2010, the Company acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.   The Company has capitalized costs in purchasing the SampleMD patent, which consisted of the following as of March 31, 2012 and December 31, 2011:   <table cellspacing="0" cellpadding="0" style="width: 50%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2012</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">2011</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt; width: 54%">Patent rights and intangible assets</td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">930,000</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 20%">930,000</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated amortization</td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(95,735</td> <td style="text-align: left; padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(82,059</td> <td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="background-color: rgb(204,238,204); vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">   Patent rights and intangible assets, net</td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">834,265</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">847,941</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   The Company began amortizing the patent, using the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. Amortization expense was $13,676 and $13,677 for the three months ended March 31, 2012 and 2011, respectively.

EX-101.SCH 6 oprx-20120331.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - WEBSITE DEVELOPMENT COSTS link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - PATENT RIGHTS AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - DEFERRED REVENUE link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - NOTE PAYABLE link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - STOCK OPTIONS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - OPERATING LEASES link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - MAJOR CUSTOMERS link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - OPERATING EXPENSES link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - RESTATEMENT link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 7 oprx-20120331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 oprx-20120331_lab.xml XBRL LABEL FILE Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable Prepaid expenses Total Current Assets Property and equipment, net Other Assets Patent rights, net Website development costs, net Security deposit Total Other Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable - trade Accounts payable - related party Accrued expenses Deferred revenue Total Current Liabilities Stockholders' Equity Common stock, $.001 par value, 500,000,000 shares authorized, 14,192,496 shares issued and outstanding Preferred stock, $.001 par value, 10,000,000 shares authorized, 65 shares issued and outstanding Stock warrants Additional paid-in-capital Accumulated deficit Total Stockholders' Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Issued Preferred Stock, Par Value Preferred Stock, Shares Authorized Preferred Stock, Issued Income Statement [Abstract] REVENUE Sales TOTAL REVENUE EXPENSES Operating expenses TOTAL EXPENSES LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Interest income Other income Interest expense TOTAL OTHER INCOME (EXPENSE) LOSS BEFORE PROVISION FOR INCOME TAXES PROVISION FOR INCOME TAXES NET LOSS WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED NET LOSS PER SHARE: BASIC AND DILUTED Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss for the period Adjustments to reconcile net loss to net cash used by operating activities: Depreciation and amortization Stock-based compensation Amortization of debt discount Changes in: Accounts receivable Prepaid expenses Accounts payable Accrued interest Accrued expenses Deferred revenue NET CASH USED BY OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment Website site development costs NET CASH USED BY INVESTING ACTIVITIES NET (DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS - END OF PERIOD SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for interest Cash paid for income taxes SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: Common stock issued to satisfy dividends related to preferred stock Notes to Financial Statements NATURE OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES PREPAID EXPENSES PROPERTY AND EQUIPMENT WEBSITE DEVELOPMENT COSTS PATENT RIGHTS AND INTANGIBLE ASSETS ACCRUED EXPENSES DEFERRED REVENUE NOTE PAYABLE COMMON STOCK PREFERRED STOCK STOCK OPTIONS AND WARRANTS OPERATING LEASES RELATED PARTY TRANSACTIONS MAJOR CUSTOMERS INCOME TAXES OPERATING EXPENSES GOING CONCERN RESTATEMENT SUBSEQUENT EVENTS Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Deferred Revenue EX-101.PRE 9 oprx-20120331_pre.xml XBRL PRESENTATION FILE GRAPHIC 10 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBJ\U[: M6YQ/0#^=)NPF[;EBBJ\-[;7/\`J+F*7_<<'^56*:=QIW"BH7N8(VVO M-&K>C,`:;]LM?^?F'_OL4KH5T6**9'-'*,HZM_NG--EGBA($DJ)GIN;&:=QW M):*K_;+7_GYA_P"^Q1]MM?\`GYA_[^"E="NB65BL3L.H4D5@:?JE\8X)YUEE MAD2/<7B$>'9E`V^HY/Y5MK/;S91)8WXY`8'BHPEG4R0EBC?<+@]!W'3Z>]7]/TF+3Y)9%2%H0SF6,1`.2,!3W!R>Q[?2M>"&PLY6BA$,(#,JF M.R?]X4$6YB`P8XY)''KQFK2PZ0A3;]E&PDK\PZD@G]0#1'%I,3ED^RJ2P;(8 M=1T_K1=!=":?J,U]=2`PJD2Q*P^;)#%G!'T^6J-CJ%X]I'N*U8X[&'_28_)0;=GF`@#&K*?^`U8COR.)4X]5J**+U%2M#@=*I7&KEU'5UW*^HZ7<3P2089AOZC/8^M7=-LK7QCH M]M=:HCM/`6B+*VW=TY_E5:]M?%?B",6UQ;P65LQ^<;NOUY)/TKJM(TR+2--B MLX22$Y+'JQ/4UI"FI3=HVCYFE.FI3=HVB.42QKE8RY5R!@5T_BS_D5M0_W!_,52\!_P#(M+_UV?\`G2=* M'MTK:6$Z4/;J-M+%JP\+Z9H\SW-FDBR&,IEG)&#_`/JKG?AT`)M2P/X4_P#9 MJ[R7_5/_`+IKA/AU_KM2_P!U/_9JJ<5&K!17A[C\ZX?P3;1WIUFVF&8Y4"M]"6J_X* MN9+*ZOM"N3^\@HKI6DW%XV"R+A!Z ML>!7FFF6LMOXDTAY^9)Y(YSGK\S'^?6NI\1LVN>(['08R?)C/FW&/\^G_H54 MM:4)\0],50`H,(`';DTZ[YY7Z)I#K^_*_1-+_,340/\`A:%N<<[X_P#T&NHU M7PUIVM7"3WB.SHFP;7(XSFN7U'_DI]O_`+\?_H-=^S*BEF("@9)/:M*,5+G4 MEU-:,5)S4EU.9/@305!+12@#G)E-=W)7'K[*/7O6 MWJVL7?BB^.D:-D6O_+:;H&'J?]G^==3HVBVNB68@MURYYDD;JY_P]JCV4*KM M!67?_(ATH57:"LN_^1S_`(@TM-(\!BR5O,"2*2Q'4ELFH?#_`(1TG4M#MKRX MCD,L@)8K(0.I'2M;QS_R+$O_`%T3^=8NA6OB>31;9K"^M8[4@[$=A?\\IO^_IK"UW1-/TBSU-;)'4_8I%; MJDUL?8O&G_03LO\`O@?_`!-8VKQ:G%IFKKJDT?^`O!NBZ_H+W6H0RM*LYC!24J-H`/3\:ZT_"GPO+&51+R%STD6?)!^ MA&^"7\6KHC?V$E@;7SCN-QC=OP,]^G2KNJ>*_&VEW<5CJ4UEIBS\)=B'< M@'J&&[I],BO9J*O*O)0J?*_Z&B-[X9ZEJ&F^*=6\)7EVUW!:!VA=CG858`XS MT!!!QV->JR2`K7!>"?"EOX;CFO6O/MU_>#,ET/NE3S\OJ">2>]=:9O>N/$U8 MRJ-Q+3T%F8@N:S*VOZ)?V6L+KVCKOD!W M2Q#J3T)QW!'4=:MVGCK2Y4VWOF6DP^\CH2`?J*ZFJ\UE:W!S/;PRG_;0'^=5 M[*46W!VN+V4HMNF[7Z'.7GCG3HTV6"R7DYX540@9_G5?PYH5[-JCZ[JZE9V) M,<1Z@D8R1VP.`*ZR&SMK;_46\47^X@'\JGH]DY23F[V#V4I24IN]CSW4R/\` MA9]L,\[XO_0:]"J(P0F7S3$AD'\6T9_.I:JG3Y')]W<_E8R=/]YSWZ6"7_5/_`+IK@_AT09M2P?X4_P#9J[_K44<$4.?+B1,] M=J@9HG3YIQEV"=/FG&78X;X>D&]U/![+_-JF\61OH^NV.OP+QNV2@=R/\5R/ MPKLXX(H23'&B$]=JXS3I(XY5VR(KKZ,,U"H6I\E]49JA:DH7U74Y7P7:R3+= MZW<SN<%J)'_"T+8=]\?_H-1>+?$+W>H2:2DGV>TC?9,_4N M?H.WMWKT(P1&3S#$A?\`O;1G\Z:UI;NQ9H(BQZDH.:ET)--)[NY,L/)II2W= MSC](\2^&=&LA;6S3>KN8CN<^IK0_X3S0_P#GK/\`]^C6_P#8K7_GVA_[X%'V M*U_Y]H?^^!5J%1*R:^[_`():A52LFON_X)ROB75;75_!LUU:LQB$Z)EA@Y!% M5_#_`(NTK3=#MK2XDE$L8(;;&2.I/]:[7[/!Y?E^3'LZ[=HQ^5,^Q6O_`#[0 M_P#?`I.E/GYT];6V$Z4^?G3UM;8P/^$\T/\`YZS?]^C6#X@U_3=5M+\6CR%V MLITCFE09!\M2YQT`)[^E M<8-)\0"\_P"$L,1.K&;!T[(_X]ON[,_WL"*XC*2H&7WK&N]&CA4O'*P'H1FBBLYQ35V3))HS$@W JR;=V/?%;5KHD``>5FD/IT%%%94XI[F<$GN:JJ$4*H``Z`4ZBBNDV/__9 ` end XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R25.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

SUBSEQUENT EVENTS

XML 13 R9.htm IDEA: XBRL DOCUMENT

PROPERTY AND EQUIPMENT

3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

PROPERTY AND EQUIPMENT

The Company owned equipment recorded at cost which consisted of the following as of March 31, 2012 and December 31, 2011:

	2012			2011
Computer equipment	$	21,554		$	20,130
Furniture and fixtures		11,088			11,088
Subtotal		32,642			31,218
Accumulated depreciation		(8,587	)		(7,287	)
Property and equipment, net	$	24,055		$	23,931

Depreciation expense was $1,300 and $452 for the three months ended March 31, 2012 and 2011, respectively.

- Definition

Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A8F,Q-S(R-U\W-3-F7S0W,V-?8C(Y-E\S9F5A M,C`Q8S1E-S,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!23U!%4E197T%.1%]%455)4$U%3E0\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O M#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DU!2D]27T-54U1/34524SPO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]015)! M5$E.1U]%6%!%3E-%4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=/24Y'7T-/3D-%4DX\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E13/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X M.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!296=I'0^3F\\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@+2!T6%B;&4@ M+2!R96QA=&5D('!A'!E;G-E3PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8F,Q M-S(R-U\W-3-F7S0W,V-?8C(Y-E\S9F5A,C`Q8S1E-S,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO86)C,3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!D:79I9&5N9',@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)VUA6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3W!T:6UI>F5R(%-Y M2`S,2P@,C`P-BX@270@=&AE;B!B96-A;64@82!C;W)P M;W)A=&EO;B!I;B!T:&4@4W1A=&4@;V8@36EC:&EG86X@;VX@3V-T;V)EF52>"!# M;W)P;W)A=&EO;BX@3VX@07!R:6P@,30L(#(P,#@L(%)&240L($QT9"XL(&$@ M0V]L;W)A9&\@8V]R<&]R871I;VXL(&-O;G-U;6UA=&5D(&$@&-H86YG92!A9W)E M96UE;G0@=VET:"!T:&4@F52>"!#;W)P;W)A=&EO;@T*97AC:&%N9V5D(&%L;"!O9B!T M:&4@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!C87!I=&%L('-T;V-K(&]F($]P M=&EM:7IE4G@@0V]R<&]R871I;VX@9F]R(#$L,C4V+#DU."!S:&%R97,@;V8@ M8V]M;6]N('-T;V-K(&]F(%)&240L#0I,=&0N+"!R97!R97-E;G1I;F<@,3`P M)2!O9B!T:&4@;W5T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2P@3W!T:6UI>F52>"!#;W)P;W)A=&EO;BP-"FES(&$@=&5C:&YO;&]G>2!S M;VQU=&EO;G,@8V]M<&%N>2!T87)G971I;F<@=&AE(&AE86QT:"!C87)E(&EN M9'5S=')Y+B!4:&5I2X@3VYC92!D969I;F5D(&%S(&$@;6%R M:V5T:6YG(&%N9"!A9'9E2!T:')O=6=H(&ET2!S;VQU=&EO;G,@<')O=FED97(@87,@:70@;&%U;F-H960@ M:71S(&1I7-I8VEA;G,@=&\@F52>"!S;VQU=&EO;G,@<')O M=FED92!P:&%R;6%C975T:6-A;"!M86YU9F%C='5R97)S(&5I=&AE'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960-"FEN=&5R M:6T@8V]N2!A8V-E<'1E9"!I;B!T:&4-"E5N:71E9"!3=&%T M97,@;V8@06UE&-H86YG92!#;VUM:7-S:6]N("@F(S$T-SM314,F(S$T.#LI+"!A M;F0@'!E8W1E9"!F M;W(@=&AE(&9U;&P@>65A6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S#0IR969L96-T M('1H92!C;VYS;VQI9&%T960@2!/<'1I;6EZ95)X($-O6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M=V5I9VAT.B!N;W)M86PG/CQU/D-A M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!C;VYS M:61E2!L:7%U:60@:6YS=')U;65N=',@=VET:"!A;B!I M;FET:6%L(&UA='5R:71Y(&]F('1H6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/'4^1F%I'0M86QI9VXZ(&IU&EM871E'0M86QI9VXZ(&IU2!A M;F0@17%U:7!M96YT/"]U/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^06QL(')E=F5N=64@:7,@28C,30V.W,@<')O8V5S6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE&5S/"]U/CPO<#X-"@T*/'`@2!M971H;V0N(%5N9&5R('1H92!A M"!A"!R871E"!A M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A M;GDF(S$T-CMS#0IK97D@;65M8F5R2!W:71H(&%D9&ET:6]N M86P@2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!G;V%L(&ES('1O(&AE M;'`@<&%T:65N=',@8F5T=&5R(&%F9F]R9"!A;F0@86-C97-S('1H92!M961I M8VEN97,@=&AE:7(@9&]C=&]R('!R97-C7,@=&\@;65E="!T:&ES(&UI2P@8F5T=&5R('5S97(@97AP97)I96YC97,@86YD(&YE=R!W M87ES('1O(&5N9V%G92!I;F1U2!I7,@'0@9FEV92!Y96%R6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@;6%I;G1A:6YS#0II=',@8V%S:"!A M;F0@8V%S:"!E<75I=F%L96YT6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE('!R97!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`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`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!D;V5S M(&YO=`T*97AP96-T('1H92!A9&]P=&EO;B!O9B!R96-E;G1L>2!I'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8F,Q-S(R M-U\W-3-F7S0W,V-?8C(Y-E\S9F5A,C`Q8S1E-S,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO86)C,3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S M='EL93TS1"=W:61T:#H@-3`E.R!B;W)D97(M8V]L;&%PF4Z(#$P<'0G/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO M=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXU+#`T.3PO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXP/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXX-"PS,3@\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^.3$L.#$Q/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXW+#8T-CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXV.30\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V)A8VMG'0M86QI9VXZ(&QE M9G0G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SXQ,30L,#`P M/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$ M)V)O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O M;7!A;GD@;W=N960@97%U:7!M96YT(')E8V]R9&5D(&%T(&-O'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G M/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,C`E)SXR,"PQ,S`\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24G/B8C,38P.SPO M=&0^/"]T6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)O6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS,BPV-#(\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^,S$L,C$X/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG'0M86QI9VXZ(')I9VAT)SXH M."PU.#<\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R!P861D:6YG+6)O='1O;3H@,7!T)SXI/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I M9VAT)SXH-RPR.#<\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!P861D:6YG+6)O='1O;3H@,7!T)SXI/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F'0M86QI9VXZ(&QE9G0G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT)SXR,RPY,S$\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO=&0^ M/"]T'0M86QI M9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O M;7!A;GD@:&%S(&-A<&ET86QI>F5D(&-O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S M='EL93TS1"=W:61T:#H@-3`E.R!B;W)D97(M8V]L;&%PF4Z(#$P<'0G/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,C`E)SXQ-30L,3,S/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,C`E)SXQ-30L,3,S/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ M(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXW,#@L M,#$P/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXH,3@S+#0R.3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/BD\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH-3DL,#@S/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ M(&QE9G0G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SXT-C8L M-C@V/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(&IU2!B96=A M;B!A;6]R=&EZ:6YG('1H92!/<'1I;6EZ95)X#0IW96)S:71E(&-O65A65A2!B96=A;B!A(&YE=R!W96(M8F%S960@<')O:F5C="!A;F0@=&AE(')E;&%T M960@<')O9W)A;6UI;F<@86YD#0ID979E;&]P;65N="!C;W-T2!C;VYT:6YU97,@=&\@96YH86YC92!A;F0@ M=7!G2!P87EM96YTF5D(&%N9"!A;6]R=&EZ871I;VX@=V%S('-T87)T960@8GD@<75AF52>"!W96)S M:71E('=A6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU'!E;G-E('=A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@&-L=7-I=F4@6%B;&4@=&\@=&AE#0IR96QA=&5D('!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2<^)B,Q-C`[/"]P/@T*#0H\ M=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS M1"=W:61T:#H@-3`E.R!B;W)D97(M8V]L;&%PF4Z(#$P<'0G/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE M/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@,C`E)SXY,S`L,#`P/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)#PO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,C`E)SXY,S`L,#`P/"]T9#X-"B`@("`\=&0@'0M86QI M9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT)SXH.#(L,#4Y/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0G/B0\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C5P="!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SXX-#6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/"]P/@T*#0H-"@T*/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^06-C'!E;G-E6QE/3-$)V9O;G0Z(#$P<'0O-G!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M86QI9VXZ(&-E M;G1E&5S/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)O'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H-"@T*/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@:&%S('-I9VYE9"!S979E2X\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=M87)G:6XZ(#!P="<^/"]P M/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^3VX@3V-T;V)E65A'0M86QI M9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IUF5D(&%S(&]F($UA6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE'0M86QI9VXZ(&IU2!E;G1E2!I6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)VUA6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^4V5R:65S($$@4')E M9F5R6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y96%R(&5N9&5D M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,#@L#0HS-2!P6QE M/3-$)VQE='1E'0M86QI9VXZ(&IU M2!T96X@8V]N6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE(&AO;&1E2!T:6UE+"!O6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU28C,38P.S$R+"`R,#$P+"!T:&4@0V]M<&%N>28C,30V.W,@0F]A6UE;G0@9F]R(&%L;"!C=6UU;&%T:79E(&%N9"!C=7)R96YT('-E;6DM86YN M=6%L(&1I=FED96YD6UE;G0N($]N($UA28C,30V.W,@0F]A6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU65A&5R8VES92!P6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^5&AE('!R969E'0M86QI9VXZ(&IU6%B;&4@;VX@=&AE('-T871E9"!V M86QU92!O9B!T:&4@4V5R:65S($(@<')E9F5R2!F2!B92!P86ED(&EN(&-A7,@ M:6X@=VAI8V@@=&AE('-T;V-K('1R861E2!A="!T:&4@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2!T M:&4@:&]L9&5R+B!4:&4@8V]N=F5R28C,30V.W,@0F]A6UE;G0N($]N(%-E<'1E;6)E'0M M86QI9VXZ(&IU6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A8F,Q-S(R-U\W-3-F7S0W,V-?8C(Y-E\S9F5A,C`Q8S1E-S,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86)C,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M5&AE($-O;7!A;GD@86-C;W5N=',@9F]R(&5M<&QO>65E('-T;V-K+6)A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!F;VQL;W=S M($%30R!4;W!I8R`U,#4M-3`L(&9O'0M86QI9VXZ(&IU0T*;V8@,C0Q)2P@2!R96-O9VYI>F5D('-H87)E M+6)A'!E;G-E#0IO9B`D-BPR,#,@9'5R:6YG M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3`@=VET:"!T M:&4@F5D(&EN(#(P,3$N("0V+#(P,R!H87,-"F)E96X@65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(R,24L(')I"!M M;VYT:',N(%1H92!#;VUP86YY(')E8V]G;FEZ960@97AP96YS97,@;V8@)#@S M+#DY,@T*9'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L M(#(P,3$N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(Q."4L(')I XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6

PREPAID EXPENSES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

PREPAID EXPENSES

Prepaid expenses consisted of the following as of March 31, 2012 and December 31, 2011:

2012 2011

Insurance $ 5,147 $ 5,937

Website maintenance 8,750 17,500

Rent 5,049 0

Consulting 84,318 91,811

Employee advances 7,646 694

Advertising 3,090 3,090

Total prepaid expenses $ 114,000 $ 119,032

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_PrepaidExpensesTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

Balance Sheets (USD $)

Mar. 31, 2012

Dec. 31, 2011

Current Assets

Cash and cash equivalents $ 797,503 $ 959,166

Accounts receivable 116,458 471,870

Prepaid expenses 114,000 119,032

Total Current Assets 1,027,961 1,550,068

Property and equipment, net 24,055 23,931

Other Assets

Patent rights, net 834,265 847,941

Website development costs, net 466,686 465,498

Security deposit 5,049 5,049

Total Other Assets 1,306,000 1,318,488

TOTAL ASSETS 2,358,016 2,892,487

Current Liabilities

Accounts payable - trade 176,051 336,712

Accounts payable - related party 570,000 570,000

Accrued expenses 322 66,000

Deferred revenue 203,153 330,605

Total Current Liabilities 949,526 1,303,317

Stockholders' Equity

Common stock, $.001 par value, 500,000,000 shares authorized, 14,192,496 shares issued and outstanding 14,192 14,192

Preferred stock, $.001 par value, 10,000,000 shares authorized, 65 shares issued and outstanding 0 0

Stock warrants 20,826,934 20,826,934

Additional paid-in-capital 5,245,612 5,125,558

Accumulated deficit (24,678,248) (24,377,514)

Total Stockholders' Equity 1,408,490 1,589,170

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,358,016 $ 2,892,487

X

- Definition

Amount for accounts payable to related parties.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.17)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 17

-Article 7

+ Details

Name: us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 7

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6935-107765

+ Details

Name: us-gaap_AccountsPayableTradeCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 3

-Subparagraph a, b

-Article 5

+ Details

Name: us-gaap_AccountsReceivableGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph 5

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph a

-Article 7

+ Details

Name: us-gaap_AccruedLiabilitiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS86

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_CapitalizedComputerSoftwareNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=6600647&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph a(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 7

+ Details

Name: us-gaap_OtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_OtherAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 4

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8,17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_SecurityDeposit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 98-5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 00-27

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

NATURE OF BUSINESS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

NATURE OF BUSINESS

Optimizer Systems, LLC was formed in the State of Michigan on January 31, 2006. It then became a corporation in the State of Michigan on October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April 30, 2008, RFID’s officers and directors resigned their positions and RFID changed its business to OptimizeRx’s business. On April 15, 2008, RFID, Ltd.’s corporate name was changed to OptimizeRx Corporation. On September 4, 2008, a migratory merger was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").

The wholly-owned subsidiary, OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Their objective is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology. Once defined as a marketing and advertising company through its consumer website, OptimizeRx is maturing as a technology solutions provider as it launched its direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution can either sit on the doctor’s desktop or can be integrated into the ePrescribing or Electronic Medical Records applications. OptimizeRx solutions provide pharmaceutical manufacturers either a direct to consumer and/or direct to physician channels for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability to the patients.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 18 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6

OPERATING EXPENSES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

OPERATING EXPENSES

Operating expenses consisted of the following for the three months ended March 31, 2012 and 2011, respectively:

2012 2011
(restated)

Advertising $ 11,270 $ 187,265

Professional fees 38,003 106,214

Consulting 6,615 46,775

Salaries, wages and benefits 306,895 173,714

Rent 16,918 7,500

Depreciation and amortization 46,023 30,050

Stock-based compensation 127,548 0

General and administrative 77,050 82,763

 Total Operating Expenses $ 630,322 $ 634,281

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_ScheduleOfOperatingCostAndExpenseByComponentTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6

RESTATEMENT
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

RESTATEMENT

The Company has restated its Consolidated Statement of Operations and its Consolidated Statement of Cash Flows for the three months ended March 31, 2011 to correct an error in its accounting. The Company did not originally accrue expenses related to advertising, marketing and employee bonuses during that period.

Three months ended March 31, 2011

Financial Statement Line Item Corrected Previously Stated

Income statement Operating expenses 634,281 469,281

Income statement Loss from operations (240,438) (75,438)

Income statement Loss before provision for income taxes (379,932) (214,932)

Income statement Net loss (379,932) (214,932)

Statement of cash flows Net loss (379,932) (214,932)

Statement of cash flows Change in accounts payable 210,735 60,735

Statement of cash flows Change in accrued expenses 9,300 (5,000)

Statement of cash flows Change in payroll taxes payable 0 (700)

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the nature and effects of a restatement to correct an error in the reported results of operations of prior periods. When prior period adjustments are recorded, the resulting effects (both gross and net of applicable income tax) on the net income of prior periods are disclosed in the annual report for the year in which the adjustments are made, and amended filings of previously issued reports are typically issued.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 154

-Paragraph 25, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 9

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22644-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22658-107794

+ Details

Name: us-gaap_RestatementToPriorYearIncomeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with the SEC as of and for the year ended December 31, 2011. In the opinion of management, all adjustments necessary for the financial statements to be not misleading for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Accounting Basis

The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

Principles of Consolidation

The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.

Cash and Cash Equivalents

For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.

Fair Value of Financial Instruments

The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable – related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature. The fair value of long-term debt, which approximates its carrying value, is based on current rates at which the Company could borrow funds with similar remaining maturities.

Property and Equipment

The capital assets are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for book purposes.

Revenue Recognition

All revenue is recognized when it is earned. Revenues are generated either through the Company’s website activities, in which we earn revenue from advertising and lead generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons, and vouchers that enable our customers to save money on medical products and services. The Company’s processes are monitored by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Company’s account.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

Research and Development

The Company’s key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.

The Company seeks to educate team members through understanding of all market dynamics that have the potential to affect the business both short term and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through technology, better user experiences and new ways to engage industries to provide new support for patients needing their products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide robust opportunities and growth during the next five years.

Concentration of Credit Risks

The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.

Earnings Per Common and Common Equivalent Share

The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents are not included in the diluted earnings per share calculation for March 31, 2012 and 2011, respectively, since their effect is anti-dilutive.

Impairment of Long-Lived Assets

The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Recently Issued Accounting Guidance

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

Balance Sheets (Parenthetical) (USD $)

Mar. 31, 2012

Dec. 31, 2011

Statement of Financial Position [Abstract]

Common Stock, Par Value $ 0.001 $ 0.001

Common Stock, Shares Authorized 500,000,000 500,000,000

Common Stock, Issued 14,192,496 14,192,496

Preferred Stock, Par Value $ 0.001 $ 0.001

Preferred Stock, Shares Authorized 10,000,000 10,000,000

Preferred Stock, Issued 65 65

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

STOCK OPTIONS AND WARRANTS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

STOCK OPTIONS AND WARRANTS

The Company accounts for employee stock-based compensation in accordance with the guidance of ASC Topic 718: Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.

The Company follows ASC Topic 505-50, formerly EITF 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods and Services,” for stock options and warrants issued to consultants and other non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered.

On October 1, 2010, the Company issued 25,000 stock options to an employee with a vesting period of one year and an exercise price of $1.21. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 241%, risk-free interest rate of 1.26% and expected life of 60 months. The Company recognized share-based compensation expense of $6,203 during the year ended December 31, 2010 with the remaining balance of $18,610 to be recognized in 2011. $6,203 has been recognized in the year ended September December 31, 2011.

On April 27, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 221%, risk-free interest rate of 2.06% and expected life of 60 months. The agreement is for a period of six months. The Company recognized expenses of $83,992 during the year ended December 31, 2011.

On May 31, 2011, the Company issued 285,000 stock options to 3 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 218%, risk-free interest rate of 1.68% and expected life of 60 months. The total value of the options was $320,585. The options vest over one year. The Company recognized share-based compensation expense of $187,005 during the year ended December 31, 2011. The remaining balance will be recognized over the following five months of 2012.

During the quarter ended September 30, 2011, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. In addition, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 11.

During the quarter ended December 31, 2011, the Company issued 20,000 stock options to 2 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 204-205%, risk-free interest rate of 0.88-0.93% and expected life of 60 months. The total value of the options was $19,270. The options vest over one year. The Company recognized share-based compensation expense of $2,480 during the year ended December 31, 2011 and $4,818 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.

On November 21, 2011, the Company issued 100,000 stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 205%, risk-free interest rate of 0.92% and expected life of 60 months. The Company recognized expenses of $8,346 during the year ended December 31, 2011 and $25,039 during the quarter ended March 31, 2012. The remaining balance will be recognized over the current year.

During the quarter ended March 31, 2012, the Company issued 50,000 stock options to 4 non-employees at an exercise price of $0.89. The options were valued on the grant date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 198%, risk-free interest rate of 0.65% and expected life of 48 months. The total value of the options was $35,091. The options vest over 4 months. The Company recognized share-based compensation expense of $17,546 during the quarter ended March 31, 2012. The remaining balance has been recorded as a prepaid expense and will be recognized over the following quarter.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 28

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number D-98

-Paragraph 2

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

Document and Entity Information
3 Months Ended

Mar. 31, 2012

Document And Entity Information

Entity Registrant Name OptimizeRx Corp

Entity Central Index Key 0001448431

Document Type 10-Q

Document Period End Date Mar. 31, 2012

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer? No

Is Entity a Voluntary Filer? No

Is Entity's Reporting Status Current? No

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 14,192,496

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2012

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: OPRX_DocumentAndEntityInformationAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 25 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

OPERATING LEASES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

OPERATING LEASES

The Company signed a lease for new office space on December 1, 2011 at an approximate rent of $5,000 per month. The new offices are in Rochester, Michigan. The lease is for three years with an option to renew for an additional two years at approximately $5,200 per month with six months advance notice to exercise the option.

Minimum annual rent is as follows for the initial term of the lease:

Year ended December 31, 2012 $ 60,591

2013 60,591

2014 55,542

2015 0

Total lease commitment $ 176,724

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 1,3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 13

-Paragraph 16

-Subparagraph b, c, d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6452660&loc=d3e36991-112694

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

+ Details

Name: us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

Statements of Operations (USD $)
3 Months Ended

Mar. 31, 2012

Mar. 31, 2011

REVENUE

Sales $ 329,403 $ 393,843

TOTAL REVENUE 329,403 393,843

EXPENSES

Operating expenses 630,322 634,281

TOTAL EXPENSES 630,322 634,281

LOSS FROM OPERATIONS (300,919) (240,438)

OTHER INCOME (EXPENSE)

Interest income 185 440

Other income 0 66

Interest expense 0 (140,000)

TOTAL OTHER INCOME (EXPENSE) 185 (139,494)

LOSS BEFORE PROVISION FOR INCOME TAXES (300,734) (379,932)

PROVISION FOR INCOME TAXES 0 0

NET LOSS $ (300,734) $ (379,932)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED 14,192,496 13,628,067

NET LOSS PER SHARE: BASIC AND DILUTED $ (0.02) $ (0.03)

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_Expenses

Namespace Prefix: OPRX_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: OPRX_ExpensesAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_LossBeforeProvisionForIncomeTaxes

Namespace Prefix: OPRX_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the federally enacted tax law.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 8, 16, 17, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4613673-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.

+ References

No definition available.

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The cost of borrowed funds accounted for as interest that was charged against earnings during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher OTS

-Name Federal Regulation (FR)

-Number Title 12

-Section 563c.102

-Paragraph 9

-Chapter V

-Subsection II

-LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Interest generated from day to day operating activities of the business. This element represents a revenue generating activity and is therefore gross (before any related cost of revenue items).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_InterestIncomeOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents a sum total of expenses not separately reflected on the income statement for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 4

-Article 7

+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

ACCRUED EXPENSES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

ACCRUED EXPENSES

Accrued expenses consisted of the following as of March 31, 2012 and December 31, 2011:

2012 2011

Accrued payroll taxes $ 322 $ 0

Accrued bonuses 0 60,000

Accrued audit fees 0 6,000

Total accrued expenses $ 322 $ 66,000

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_AccruedExpenseTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

PATENT RIGHTS AND INTANGIBLE ASSETS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

PATENT RIGHTS AND INTANGIBLE ASSETS

On April 26, 2010, the Company acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.

The Company has capitalized costs in purchasing the SampleMD patent, which consisted of the following as of March 31, 2012 and December 31, 2011:

2012 2011

Patent rights and intangible assets $ 930,000 $ 930,000

Accumulated amortization (95,735 ) (82,059 )

 Patent rights and intangible assets, net $ 834,265 $ 847,941

The Company began amortizing the patent, using the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. Amortization expense was $13,676 and $13,677 for the three months ended March 31, 2012 and 2011, respectively.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16265-109275

+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6

GOING CONCERN
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has sustained substantial losses since inception.

In view of this matter, the ability of the Company to continue as a going concern is dependent upon growth of revenues and the ability of the Company to raise additional capital. Management believes that its successful ability to raise capital and increases in revenues will provide the opportunity for the Company to continue as a going concern.

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_GoingConcernTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6

RELATED PARTY TRANSACTIONS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

RELATED PARTY TRANSACTIONS

Operating expenses consisted of the following for the three months ended March 31, 2012 and 2011, respectively:

2012 2011
(restated)

Advertising $ 11,270 $ 187,265

Professional fees 38,003 106,214

Consulting 6,615 46,775

Salaries, wages and benefits 306,895 173,714

Rent 16,918 7,500

Depreciation and amortization 46,023 30,050

Stock-based compensation 127,548 0

General and administrative 77,050 82,763

 Total Operating Expenses $ 630,322 $ 634,281

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_ScheduleOfOperatingCostAndExpenseByComponentTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

COMMON STOCK
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

COMMON STOCK

OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of March 31, 2012.

There were 14,192,496 common shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively.

On June 30, 2011, the Company entered into a settlement agreement with Midtown Partners. Under the settlement agreement, the Company will pay Midtown Partners $57,500 and grant 100,000 shares of its common stock. The cost of the settlement has been recorded as equity issuance costs. As a result of the settlement, the litigation in the Eastern District of Michigan was dismissed.

During the year ended December 31, 2011, the Company issued 475,820 shares of common stock to satisfy $500,000 of preferred dividends.

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_CommonStockTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

DEFERRED REVENUE
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

DEFERRED REVENUE

The Company has signed several contracts with customers for coupon redemptions on their website. The payments are not taken into revenue until the end user redeems the coupon. The redemptions are tracked via their website and revenues are recorded as the coupons are redeemed. Additionally, customer setup contracts that have been paid in full are deferred until the Company has completed the obligations of the contacts. Deferred revenue was $203,153 and $330,605 as of March 31, 2012 and December 31, 2011, respectively.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 5

-Paragraph 83, 84

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.3(b).Q1(c),(b).Q2,(c).Q3)

-URI http://asc.fasb.org/extlink&oid=6600647&loc=d3e214044-122780

+ Details

Name: us-gaap_DeferredRevenueDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

NOTE PAYABLE
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

NOTE PAYABLE

On October 5, 2010, the Company issued a secured promissory note of $1,000,000 to an investor. The note accrues interest at 6% per annum, compounded on April and October each year and will be paid at the earliest of September 12, 2012 or earlier at the Company’s option. No principal or interest payments are required until the maturity date. Accrued interest was $15,000 as of December 31, 2010. The terms of the note also granted 1,000,000 stock warrants and 1,000,000 contingent stock warrants in connection with the financing. The non-contingent warrants were valued at $1,007,992 with $1,000,000 recorded as debt discount and $7,992 recorded as interest expense in the December 31, 2010 year. The Company analyzed the assumptions associated with the contingent warrants and determined that the performance objectives were not likely to occur in 2011. Therefore, no value was recorded for the contingent warrants. The debt discount derived from the warrant valuation of $1,000,000 was being amortized over the life of the loan using the straight-line method and charged to interest expense.

On September 16, 2011, the Company entered into a Termination Agreement, in conjunction with a Securities Purchase Agreement with another investor. Under the Termination Agreement, the Company paid off the $1,000,000 promissory note, plus all accrued interest to date. Upon payment of the note, the contingent stock warrants obligation was terminated and the remaining debt discount from the warrant valuation was expensed. See Note 12.

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_NotesPayableDisclosureTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

PREFERRED STOCK
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

PREFERRED STOCK

Series A Preferred

During the year ended December 31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.

The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management’s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion price.

The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.

On May 12, 2010, the Company’s Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November 16, 2010, the Company’s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March 25, 2011, the Company’s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment.

Series B Preferred

During the year ended December 31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 2,000,000 shares of common stock at an exercise price of $3 for a period of seven years.

The preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were allocated to the preferred stock.

During the quarter ended September 30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 12.

The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management’s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1.50 conversion price.

The holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. On March 25, 2011, the Company’s Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September 21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6

INCOME TAXES
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

INCOME TAXES

For the three months ended March 31, 2012, the Company incurred a net loss of approximately $301,000 and therefore has no tax liability. The Company began operations in 2007 and has previous net operating loss carry-forwards of $13,479,000 through December 31, 2011. The cumulative loss of $13,780,000 will be carried forward and can be used through the year 2032 to offset future taxable income. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.

The provision for Federal income tax consists of the following for the three months ended March 31, 2012 and 2011:

2012 2011

Federal income tax benefit attributable to:

Current operations $ 102,000 $ 129,000

Valuation allowance (102,000 ) (129,000 )

 Net provision for federal income tax $ 0 $ 0

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of March 31, 2012 and December 31, 2011:

2012 2011

Deferred tax asset attributable to:

Net operating loss carryover $ 4,685,000 $ 4,583,000

Valuation allowance (4,685,000 ) (4,583,000 )

 Net deferred tax asset $ 0 $ 0

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $13,780,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Statements of Cash Flows (USD $)
3 Months Ended

Mar. 31, 2012

Mar. 31, 2011

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss for the period $ (300,734) $ (379,932)

Adjustments to reconcile net loss to net cash used by operating activities:

Depreciation and amortization 46,023 30,050

Stock-based compensation 120,054 0

Amortization of debt discount 0 125,000

Changes in:

Accounts receivable 355,412 (112,911)

Prepaid expenses 5,033 61,467

Accounts payable (159,640) 210,735

Accrued interest 0 15,000

Accrued expenses (66,700) 9,300

Deferred revenue (127,452) (50,270)

NET CASH USED BY OPERATING ACTIVITIES (128,004) (91,561)

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property and equipment (1,424) 0

Website site development costs (32,235) (37,610)

NET CASH USED BY INVESTING ACTIVITIES (33,659) (37,610)

NET (DECREASE) IN CASH AND CASH EQUIVALENTS (161,663) (129,171)

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 959,166 1,278,094

CASH AND CASH EQUIVALENTS - END OF PERIOD 797,503 1,148,923

SUPPLEMENTAL CASH FLOW INFORMATION:

Cash paid for interest 0 0

Cash paid for income taxes 0 0

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

Common stock issued to satisfy dividends related to preferred stock $ 0 $ 250,000

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_CashAndCashEquivalentsBeginning

Namespace Prefix: OPRX_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_CashAndCashEquivalentsEnding

Namespace Prefix: OPRX_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_AmortizationOfFinancingCostsAndDiscounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

For each income statement presented, the amount charged to expense for amortization of capitalized computer software costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS86

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_CapitalizedComputerSoftwareAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Value of stock issued to shareholders as a dividend during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockDividend

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

WEBSITE DEVELOPMENT COSTS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

WEBSITE DEVELOPMENT COSTS

The Company has capitalized costs in developing their website and web-based products, which consisted of the following as of March 31, 2012 and December 31, 2011:

2012 2011

OptimizeRx web development $ 154,133 $ 154,133

SampleMD web development 586,112 553,877

 Subtotal, web development costs 740,245 708,010

Accumulated amortization (214,476 ) (183,429 )

Impairment (59,083 ) (59,083 )

 Web development costs, net $ 466,686 $ 465,498

The Company began amortizing the OptimizeRx website costs, using the straight-line method over the estimated useful life of 5 years, once it was put into service in December of 2007. During the year ended December 31, 2009, the Company began a new web-based project and the related programming and development costs have been capitalized for the SampleMD website. The project was completed in mid-December 2010 and no amortization was recorded in 2010. Amortization began on the straight-line method in January 2011 over the period of five years. Although the Project was completed in mid-December, the Company continues to enhance and upgrade the website. Monthly payments for these upgrades and enhancements have been capitalized and amortization was started by quarter in 2011 and continues in 2012. The Company determined that the original OptimizeRx website was no longer useful so the remaining unamortized balance of $59,083 was impaired as of December 31, 2010.

Amortization expense was $31,047 and $15,920 for the three months ended March 31, 2012 and 2011, respectively.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: OPRX_WebsiteDevelopmentTextBlock

Namespace Prefix: OPRX_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 38 0001255294-12-000308-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001255294-12-000308-xbrl.zip M4$L#!!0````(`,A"TR,#$R,#,S,2YX M;6Q55`D``VAXLD]H>+)/=7@+``$$)0X```0Y`0``Y%WM<]LVD_]^,_<_X/S, M==H9R1;U+B?M,XY?.KZFB6LG;6\F7V`2DM!0I`XD;:M__>TN`+Y(E$Q*=)H^ M3S\T"0GL_K#87>PN0.CU/Y\6/GL0*I)A\/V1<]PY8B)P0T\&L^^//MZUS^[. MKZ^/V#]_^,__8/#?Z_]JM]F5%+YWRBY"MWT=3,-7[!U?B%/VHPB$XG&H7K%? MN9_@D_!*^D*Q\W"Q]$4LX(7F=,IZQ]U[UFY7(/NK"+Q0?;R]3LG.XWAY>G+R M^/AX'(0/_#%4GZ-C-ZQ&[BY,E"M26N]./YW[4@1Q].DFN?>ERV[%,E0QC/_3 M^V4L%_)/P6Z?8`@*'O,8P'^ZNSS_Y'1^^=3M.-U/OR1=P8G3_]!U3KN=TUZ_X@AB M'B=1.H+.4\?\I[N_?KI7OCS%_S.8W"`Z?8KD]TO1-\?<^CC#("W-%^ M`PF\]>*T0[[QX$2_+#25I4V'NJFT33VQUBX2[O$L?#B!%RV.T^XYMKD2 MTZV0AR?PUC:44=CO.J-=X],M;(*-"7T2E?>A- M2:<@#()D48[+B]5)O%J*$VC4AE9"23?M]WRG8@?`@(_+T=&;$G3O;VY_3SO@ M/ZA-IPOIE*\`:$ M4A3$9M7K_/JGHQ_`6IU^?]SO.:]/UCMG[$Y*^1EN2Q!YZ&VB`-M1,;J8'[+A M6$K9NXUNX&5SG7#<&7NOT,4^+P"P#XU(M\OY+'H__=O*5GNFN$1(]DVC0G+: MP.;O+"0S@)<1DK%8)V>QSM]2JPH6Z^QCL4[3%IL$4@OYX]W%AC07@D>)$C^8 M=>P4VEAB]E61!5+;0O]NSI6(MK(P0J!&>_,`?#=;^'CR`:9Q4[;8]QVN:AC/ MYE[7E\$ZQC*J.:87(@@7,GB.[?-R6>=;1MB^+TBA3*`0$IU>DD[?BIF,8@56 MC,$H,\ISBVOPKA74AM(FDGY]LHWB)L=S,";%_6N(KY]^$JO*+/,&NY5:GAW$ MV3`W0?P!0H;*7)Q.^Q=-/]^]C.P-&=^E-LW*]/,KS59J>79G\-;#%E<^GU5F M,^5^)#2'`H$\Y?-$*7PL(Y?[_RNXJCN6MET-=E';5(#?A.__%(2/P1TH>!@( M[SJ*$O#85=F^"_,*L(7:)MM?0S\)P/NN*(>-]F2W1J5$O;4AJFY1=PON8SJ?DJ?$G@>K/(0"Z3([T#.N]?<*GE4?ZR]K-K!! M:3L[5+!ZS/#O9>Q22B53&2X687`7A^YGO=R\3V(,>+"84N"[%@,S=+7TPJQ2 MS!.N!&%#!G7][@J<3-^9=/N386&J=S"ST$P">?I.Q->!&R[$VS"J+($,%<8` M.4@=L.1>IS/J]5^?E'*HS;XLA-O-?C29]+H5V5^(I8+>5+LY"[RS!2KOG_3/ M)F31'W:ZO0S*#FX'`JLK)9BC061C%$72]`$,(P:LU MHDHYA%79-@FWKE"=[@`"B\,Q@[HJ6(#$A=!_7@=GKFYY*UPA'_B]7WEAW:D$ M@T'?R5E*%;Y-8:UMUH[3G3A.TV!OE%ARZ5V(J8#5T;M\6HH@$C`Y[^.Y4&=1 M))K1Y$&GU]N%O0J.EQM-WVV\7W?8+P7\K^;WT92Q% M,V'6<#BJA#K'MRFL=04\Z36/U/J66_$@@J0AY]`=]0<[%\0UKHW`K+T4#CK= MT4YY/H,2M/:<1_,;%6)IQWNS^ABAD2FS0C\'XW M)^[JS)N%75?UA\2<-AWX31^A"2XZ=RNW>MV\VMT1=8- M(MXC-1XZG8,1;[&#Z^`!UL;FW4>O-QQ,GK7"$N[-XCY4V/5QXT;W*?8!A<<_ M4.D?N(^&\4;,9!"LEX[VE/!D,'&&P]+IU^P M@%+B>R.H(@S'F73RA?U*"'2MZ="Q0\(UR:<"!:JU658:[``\SG!76^'B] M0E)CT-U^9S#(2WL[BT/A5!%(MS?I.?O!N9)`5KR5#U3"X<%,@N%H>1X@GW&O MWQWF!+2;R^&8J@AIW!]-^LZ^F';D`P?(J3\<#L?#2EE'(Y@J^=7AH#\9[XMI M6S6]CD?I=88%=[JC,/X,NTK>I.>,^^-Q)7:'#0Q2XG''&:[[K>I,*OD"B''[ MX]&S3(HU\@^*>P>O@J-A9^!L+L@E+`Y$4T4.D!J/\AMX^Z.Y%3Z/A7?#%6:@ MI@^XU7=AX!XFL<&H&#G79OPBR*M(]R60KY6YFQ1TKUO4A`JLF@-819[#X;HX M]X"XJYY>QTUU>LZ@<#)C9\6\`M=J]@I>?U"9ZZ9H]AWNI#\9='-.>9/R?KRK MK3WXW<6H#O/<^:6#\F$Z&Y5;Y=?([L.VTHCKL?T-T)&06SF;Q_6/AI7I M][@[G.1/8>WBKV!\/"REE._P`8 ME588ISL8%&H.U6#T)%F#;&J_W]2V?K4(P MGCBC6LQSGA>,KCDY;`3]SS%J`MA>B4)=8'?<%Y%9GALZ*-/K3OKY(NT:BST0 MU#[\.>F-^]41F#>-[.:M#][2KL/ST.%NXYENY)N*8B,#'D+TDP_,-YCLA:+V M@;U>OSMV*J"@;:.7&'^!<&5N^XZSE%MV7D8?X]*GPE-1-#%:9UPXM%?*YP`X M=<71+YYTK`2'*D.Z3<,[?3G*-9G65H-A):Y6(D91&C\%6:"^!_/Z9Z3[G;63 MC#LAD&B:-/:"^A>HUV9=?^P]2'+[S[`GOX#?@;P1TY".%3U(O'/D*C0J\H$_ M-75LQ7P%4XWEX0#W_DZF'L!,M>PG-)8M[H2ZDG\"SC:^XSKP_DBC>[\3@LQ^2'8CH!0>V M>UJV#:PW[(X[^0\6&AK8\W-\(]0;'DF7OO;)R.]E&C=;AM?N''=J*=X64"\Z MNF?M:=?H>B\PNEQ1[H:K]PJ_AA7Z_`Y0V!S'KFQX&W:`WG%*ZX#;6#:$LC0U MWH:R29":Q5D2ST.%FZD'?=DZL'=7E:);9W4@JDV1?1E4^@Q90U\`/\/E`#"5 MQ;,WF!ME-D.^J$U6X]HN!84NT=_)3Q!EP.9 ME-B4%MZ(0$QETU_05F/:'-0#OM7:#ZJM3.$VYPO5W9!T7;8'R&$WV[2.\B(# M+E#?@_E!P][)O/Q\O_Y88OV[U6:^?1PZP^&SGT"4`V@:?/T:9G?BC)QFP-,: M#IFP/M$*IMC8AX\.WJV;J\F5<]H?SP':6`W*.QXG2KR?UJ]5_O"-'[]:LBA> M^>+[HP57,QF^01FX9J`<&A#%@\%W0GM"`PX93]+-VYG/&`@>S_AP<)5RO6`]0NETB-6(>,+#'.8BD1F\"8T$`>-_'MMA?ZO`>I1CFSUZ9\T9$ M?CM=5`#FM+J#86LR&.O!$@R7>E6V1J5D&T!ELZENN+^&Q*B=(E"T>O!"@Q\0+I:QLB#3-F M*(.\D4[!>65V`LC>B0?N<9S:*/%C;08TI=EI7CNP*%:)BZZQA6VT,F]1>V-& MFGC1'&5$Y)>\0)U>X=1MLR.>^9-U/J!!1D1"C8N>`^>$L77:D,/("@5L?L`]EK>/^'P"_:!>E#R.[) M`]^+&'\/@;NNL57S`$D8S59A,INC3P^P/_19`D(,>\#5SE>1="4W3F`);FW! M70$877!'(*QDRDE_%:J@)I0-!XW1%1`Z3/&X(.,X6)#F9ST>),@]6#IB&5DS M2T=M:$G]Q4J$M_2R1P%"C45!HC#4!<861'"K,)?Z"@"%32`=\WD2N'/CQ[0/ M1,FD@R4HMC?H`4??\//%8/7/IT M355$W5FL)`CO(4P`@W;$)R'>G]I>,"R8N"`(XK##+:H8&56 M=4AWA9YI`F%'0I-JZ9O9HY@&%G`VYP_$S$($O5GA*JZL,D0X15JKL;_,H2A: M+EG+%$;EZ>.4*QO::<]OM*+4[94[P(U0NL1WYN[2V`C@-[(-\(H28@O\.%1_ MMH/?Z(>@$%)$'\!QOO$Q>/D;AOU(.<&_X"XG15LW.F33$25B25X.E4]JT(Z6 M'&^R/&7MSK&SC'>O1:`SVI&B\B4!3SS0,$^O.!2:+\B@8'(\,OBIOBB3(DQX M0#X*4$+(39;XV;?2Z0V2!AU$OTZ!.T_GFOR>*TFI9_3C0ZCLJ+[+.$V- M",-'_$36TVF-CE[I!TLX*3GJLTI\_8*R'UTUQDMB\/VES2!PEPN"=O1ZWUK7 M-GIU=WEN_S%^]9VVJ@ALT??0R4'>3DA@]'_`&I!F!&D.8D15+A&D%82(F6)$ M[9;T67@;XIG()^]JKR`UA$EO_P1$?6B9\@*HN"#!,($PP4"GA6]6L))`$N7! MG*56>2%">:AE M6#9*3NM:[%\5M:9^+?/7C%S<2[NT7:[+&!!+(FUFZ$!4`HIY;YUOYG%L,%#7 M";&M#BCG2'X\.[O)/$F.Q7N'2.EC.[6 M>$M=+`[$U5&)CUEZ^GIKC+9M^4%`M#_,Q]#=G3/,`3R MT^TT&5=;XZ`BLQ'BR0:J`ZQ-5)$80,*HU-\A&)'9TN)((B8O6>F5S*%NET MQU)3?1%M_6H5L)9GQHVS=%G&?[#<-MI7[9>O4%D2\')1FGKH@>1SJ3)M:.4# M?W)KIEX`3A*I5-UG8G]:TS6IPC[P<+&R6VE MBD=.3Z57S[5T*@ZJ),QG-JW,-R[U)2F;3YB9F0$`5/H*%=PKB% M%3+G2TQ$HN_?X,NE"I_D@IOT%ZMC=%\@XPOD9DPFR@7WW@(;VL#!:2,A5 MW`9)+5A`A24=4ATX3'[SV M@R#OCMZ8ZOM@"I3*10RW-F=FWUEQ7`_;O@QP#SR>0]0`ZNOE?N`'2P\$XCX, M/Z>KS+^4^JQ'D-IKX,[`+)!?HDZZ;=B8JU@G)LF9(B(\[?R(YR[P1RDC!G,* M>=$Q04D_A$>-T34$5`JS*9'N%>/IW=*YG=U'08Q2.+1SG-L"([O" M(AOA,*Q1??+4(!:@?F&B%"Z9=2R>QBM-(Q+=ZKB.;A/$=":@CU<$'.XH#=@'1A@0\PB5NAU%V9KR&ZP MF.TP]2!=$14**'GI06NLZQG9`S&)6R5:'/>X*RB57KJP&`P9+6#U*5]6=LY( M-*[^"7G$P3&.M^)9F2(28E'TJWDZH0C5(U>F\FRFQB0#FQCS2_._L`&;+\/I ME.%?9;D&0TS?W^JO.^BB2"_G?NN&MKD$C4Q#M(BC^"R9U1<&3\"6Y?TQZ. M3+=DL_IX%M"E=6 MZ(,`)/L+\"=^^-7&25O\VV>!MH$U;*WPZ'))/VG#2P8)J;$9II<-$7CQ!8W; M^&X6`/#T2`8M3S'HJP=_VL5`[\L#`UCMHKE<:@W3IT%XD!X8R,?K.G=.+^Y* M2;5,\@"JIK?P:0>_Y."*.3IC;6MM%QUC`B3Y0A$:ZQQW![`&=[[&)/L`)0*9 MB<_I\0@!RSZ><".-L+ID@Z<$O7)ZNA$5BPK*>#*(>:N`+Z1KH@TJV]'DA#$> MDH3)@]GBX&--E3P]AG@?8L:&B25+DT;R?I!&XA(`SW3$&G+9C97Z+RRUSHP`8YFJQ!'ZVAK4\\*$,9.8:!N.5JBC<4-^84 MLC0F0G(K,!=PC>Q-MJC(S?*2MC_?RMN@?>0K&LI"B)CZ,;,Y7CCDE9V.:MF. MD.PH\M)@#H&U1S1;2_'_V[O6W[:-+?]]@?T?B"+%S05HEZ1$/=*]"SA)6Z1H MFJ#.W6(_4A)E\Y8B=?F(X_WK=\YCAD.*E"E9LJC'A[:N30[/S)PYC4R8X5P;G6E`'0OQ4S`=>`.'U(5# MD3TD/HQ:JKC->)+"9/-IAB&_74J`.V'Y M"_:942(9#!<)AA>7]E<*QI^+CZT+`8J*0SF.('+)AA!$^H0^(@3T'T'Z5R?= M>9*QP64$P0N.2:"7*B6EH.K`!0MQXD5_@<\`JRVE!X^-.1/<5AD1N?`>(8G> M!WV-ZK\P!8+T0@BR50\8Q*>%(D9"61USD&N/0C:BL24^G^93E7K[QP;/6D:;[00GNH$VBW/]E2\"'FTS5&%+TQXQS^IJRG(@=M=6C=(4X/ M*K^Y=G,4]AV%$*^+#:_.28M*+KP9W+'*MI2C235P7SSGY4DKG')QC4_10XOS`<2:KE[!V*TCK/#`/C.QD M>`3M9$2([:37/G$QE%;0I!T73,2#&XM,OA)9@A\13V@]4;H/9ATY3]-!>FJ8 MI^6R+?VJ9D\NGA9/7'&^.BQ"&/C)-"`9_\!(VZ6O%8N6)>C*>>0/<-2`CS&9 M+DP^6T5">HI3#;.G::\LX">2*&;Q9D8*S?("J*[86,&PIN=5"XU%BK%#HE MKU!JP!TJ612SN4FA"))IOH#C0@:QE_&UQ"F^*T'G5,6)0UP1O@Y!!P6617_C M%$)\>.4A"7]"T`?O3J8!ZD2:2"!K'9.:RV8X?"B5&:KJ&^14KB5I\JC?[$C) MP[W/$26_$L`V*M?[0Q"&VF2P0E,Y4H(4+W<.XE.B.H"]QTO3]7Z M9<#V6%625TJ^WG1-]7Q7?!4^F,C1T*X1EH8D?!)G6;PHG@:> MPS=F-5/A7Y:?`QK$-*)_?-=3-#.=-+CX2.@)7A6[;V#M0F.%#6SAF@_QX+Q& M:G2[_M2]`+&V_B'\,6E8]HD8\TXHG]$,-B].WAC)W>2U8_5-IS5F1#KGRX#S)_&U9EST$&99VNAU,0Q4/9*&%.'DSQ]LV>/3I]QQK8Y*NM)QRAZVM]N/RV6 M8?SH@YOD*WI##[;R0W/0'YP^@PW&_:.639H5T\Q5-QK@UY.3W<2>V6HC-OE` ML5$]TQIO<8T4B[*5O;<+F_&RKEV3NI)DY]I==VR^8-RF6ORYY4;@MS`[)/0; M-KN%.;CAT)H.;_=-:QLEOF'5GGV$MANEFTL[-JU>"\_3\Y>VYA3]@-[`XE?/ M<3&O=1:O]F^@NM3/(7BBHYDJ33T*]W*;$!;!MOAR7AAF3684V83H)`>4(:%# M.9N-=8YF#2JXSN.\\N=]N9YWCEQT\4A?/-(O9BBM^*C?47Y<4AS5;63Q'ERS MCFVZ[A;VQ0E[JQW+M'M;J2''X:YN98_]G"=1@"E`!*WT#7[>5K$\O`EAVZ8U MVL(9=;'-.K*P!Y#T34=#(W#M3[?Y!-/J#N8XZCGFH+^%TG]L#C*ABCH[]C0? MB92^F4[S14[(33JNS-&*D][%J;:'E>V9X]X6@;^]^-3VYFTZ5)G+>QTF MC1W;V)'IE6WV+`O/YZN^ZR@(M:+6GP`R"2=_K5=KM=AH?XTRGO9%EO)A.8=( M@XG9M<_R@"V1]!)T1N3C-M,I51`S=$Q0--D*D@)"3>R<^/F*BD8D>H3$-SLN M-^.ACLUGSOCW6R?\-?.RVE6SQ-IR;4/9W>`G!T_J^EIW-/R_[:L?MF?[AM_ND:MV1' M^.JU/>J9?6?;U/]#^PDWT@D**(VCO:M>NV/3&FVEW%U'PS,P6@+L7YQF#^]M*[9'^\D6>#B,5_O69WXT)R/%24)"%8X;9`2 MZ4_E$_M4YQ*)N5/3#F6.\#LN(>*:1HP`\AEZZY=Y1FW#&;D7O+O*RPI4B!<= MRQI>&^_+R&7LOF_RR%KC,KX03Y@`BG7G\+\`U:7`;N0N1TE\EWB+!8/M(R$K M0DP#8=2=U!(-7_O$\NN@1@;-R'T):?V M)4C$YS;SJ(6@]AD<^A[Q)F&2^5(L-D.UJ\7Z"$&:\!%Z41%^#J]KZLOG)<3; M3`Y6;3^M[PH":.I+!(2GF8MH2!(\)IM\Z98#/FR$Q3/T@."ZDIL<3X@:_3]+84$Q6)8_2'%!&W7'#L6DB*/ZF'#@NI5 MKEY8$]HKA0!OJ`<;5SD<=+OA]"66@VA/Z.)V06^H; M%]_N^F4=[.ST'+%K=TN'0(.A7T4S>,]M&K@/\?L@G88QM%@Z:M=`-1\8P+.A M%06TF1)"!V:4>-.,.J\C+45W8?#O4%=B0ZR++YOGD%^TR!AFSZQT-,K&%9GW M%_1Y!N>T[.X+2,4A>;FC&77`@X&A&S)"P^.WJ%_`%_3H%1^%48'2OP3Q7P// M6,U93O3^T050@SZT_!M\$AK^W:A>EM`'0TZ<6C;36JCE*;HBHF\4\6""R)CG MT'`0>]-RDX]BCJ4T;.7C11?G1&R4QZO)L/CB2QYVZ9-\*">DG-:O'*MGVFZ/ M_'"]GF4.+/=96=?[\<*U/U`E?QPU\KF%9BA'?>(TM_6[.%G&W-0+N,"UT$Z` M?[@KCHS1O+JV+!O:L7+_@U)K&"_/[N.$_/`UF-5GXIX6$B&!`(?XE]TW[;%C M]L>#2J\CZB*@`AMZ$R!Q?-M`?;WM)\BX]<\\@TA4G@1=/F%'CJ,3G&/ M60\D9!92`SGO+O'I)VQ&]S&89?%#9'SFSL+7Q9RTIN!U[Y<_BKU7Q)VR,J#Q MRB4P6KG)=]!V2:R$?JS@D&#K1^T8Z910)ZXTD])7HP?.*8IX_0J!2L6,FE1@ M-`D#F-`%Q?"0#NHRL3H:S0DZX9&XETV)J,0W'?QG"R-B>!EX18]T8:G)(R!Y; MUQPW8ULC8NR>JS>0(U;&.Y"Y''3T5SV3.?@:6P45(HH:3XG'7KFVBRQ.D@H( M$:(HP@YW,72UQ0/RRC''(Y<&`A'9L'`,)X'@B3I#,-!A3,S[ M.(36\O(&K/8\!-:!-O+B6N1L#\A86@177@1MZ@I9"U<^QG)5\@TF%)5ZD"E1 MLO(5L=]&PHUF@=V@-2)\82&K5P6C8$LW-G0E,YJRVWR20Z?:('PLNDNJ.Q\Z MV-*Q**CEKLO2&L3>47&B\:-V+_VMK(Z0_I)IO7AY6[%M%;272WPX$MA#SIMG MLF,='L`44S3$5@3<_`Z((V6CU+A29FB4C@7ROK@G,Q][":?^%/L[TKXD'C7H MA,[P8D:T;+03>&MBYA`.@2E/XB@5_2P8S&>>Q8];/GS>/A[3<<3FA5MF&(#.UVJ4182V66J M35FF6)P<&N@-6.UP6I$_Y?V7W?"J+(T=!WD!@8%?V=HF(QVXEV=BBA3"!`_7 MU,M32##"'KB*\[4]@O;LM*S%)44'(R3V%[\4-R#DJ!6;>,T&@!J03HOX2)I/ M,"]/[+$W`[K(1DD-N):"B,ZAN#)!`,R@/SR;(8_8)]Z$PT^2`\F*Z;_H0<-$ M*3]94/=-M@/$&@F;IC2X,!Z`;F%*\3/:V2B,)9P!M>&-8NFJ4H+AVS)@KP/) M!=567N/CA9B6T(*G\7$KFL2MJ#(HEQ/;E&':GVL&>.':="*M`'MG4=(7(22$_%)^FX MBAA[*V(&YG!07;?6Q-SZRZRR.H[=0-#?UM+A#LR>574\M:+C/,[+80W,MQ<# MLZ7GQ"+NM]L8F'9A8,+-*=YIM@GMS6S"BBJ^@5UHU-B$SC8VH7+"]PYL%W:! MB[[4F&^8,5_'#D@+]FKVTC0&."E_5O&2HL'=;GM?%6;X!=M)ENME>Q?*'NFSP&?I6UJU>]OI@"+P9R M:!C&4UP*8,V:H7'*(W,L9K;R_(JY)C\M;)LZ+W1I?6%%2".M#EE=DI=U M(LH"%1**-=I`S]*U@:>D(M@'X,W_ZHOE3'8I),GCMC/G69V0M)\0DM(U4>\\ M6R\D=W?42"K7'+>1ZYK]0^I_F^!S+3]+V00WYDQ633\D?D!"<'G5&@)Z0 M*F[J.)?%Z;YL?(I"EQ`&V+.]@,Q=E4`#;R4SO,N5Q7>7!S-9YWUS^\[X$B^# MJ3&T1V_P8^KU*P.7N/1+J53P)85J(G&K1H1*;X7B>Z94S#N(IF&.%^4=VX?S MRD0,NGW$LUE,5^$TOHLPF8^EPCR`'N:!.`=XI=!G)IH:'1"4@Z9,GUU6T.%X ME"JG4XVK7,N]$O8V,.W"3\)').:G#U]^-L:#*WMD&E)(#Z$D"A@<^`-8G`WX M#U&:)3FS$V@@<--]4';:)S#CX`^1(9L!TPFYF0*#BL'P,9W5"WA`V2FI*PT8\X7HD_"?=9NCD*JW%*K:[QMYA3B=1% M<72EC@%9H>I4%KZ8U34C!(JG/\PIT^K<(KD\#75I2RM.B1-0O6C%^=3":W22 MU,5=G*(B7:\Z;ER%8L&76",OO2M5RT3.@(4)A-N$QD-*WP3`$<`'$`H3.=21 M+TA[625)YALJ1@&%1ACOR1TFI@D9DHEQ2&DN%DEB-J`1I#QI++Z"V56@,#U6 M\$IFY"EAZTHN"&7+0]8F)"*>A:`1^L^G:1:7PV@U`3_=[^A0:E69J\E#I.X" M/`^>`?XB6.C">1)'[*['7:OUN-C7CDV<(@='5Q1R#-P1*@.24F'!AM3@AMY" MD=&5T#'B$&P;'.$*!H<'%O',#XMK5`=S3W.NO7A3Z&>/@1\BU=;W)K+;%$V@ M&,QOL%^E)]WIV^*!)$C_NIH#-DB`*<1I5ECUU\[@>VH"(D>1.$<#BZ%$RG`Q MVKVIWF8_4D;[>.BQ3+44#*Z#`R0L0/Q%-UUSGHQ]?RN_=>RL>? MLXG+U[Y&B]*XU^2YGL_YNQ',&6JVQ[`N*5T[?LHU47/^@@AY%XR,1H>F=3WL MK3M>1KNCI;D:]G6\X$^.L^9HJ?-W;;4\7D7Z?I"N.G:#;T^=104Y`RLYZIGC ML4.I#QNF<9\/>Y>228JRDYH,=H=R<;6(@,;3&WN896[52I MB]&%,13[Z#YQ$:D2)/K@ZMV#)3'E*T>I<65\)X2>8SPN!``\FQC&]A&_'<7. MFL]B0]P,2>#862F8]](A2'EW;)R_O\O@NE)E#Q3Q,\[F)FH\*6NQ$!LNJ@8% MS-GM'46*Q>&L&_$G7H?^E6.YZ^\JZWHTNK*NQ[UV>MA3EY4]-ITAK9.F:&Y[ M7]7[#:@"J#^R6MQ4BB&X4YPYLD?Z:V6>:BA/W^:FDWFP.-6+&W3/RNIJ3K&S M1F,]1W-LG1R05ZH0`\[6WHZRA67V^H--/1HV1S;%.05756]\@(-Z%L>S\4YM M6-;&VF6WX0CURX[W=8=H-#ZN2]4>/V'\6=<#M^$0]4>;&7[B$(S+'E4DH;A+ M^\]U09)F,Q1ZZ&"3PR9OU<8#5XM.X($>C+E+>@2@E;DH*>I6Q/WD!,-6P%:G MN\[;9U1LG2I1S;GX),QP#T(QO_GB$*>?YK_Y:>J?(NH7(WYY1@@SY13\!R&@ MYG!90*&Y+U-ME8+/>@/?+]YRF<3?,!1JX)6.8/IX0T$>((I*$EC%P.1R""(Q M!;%E@'9B*H03>I;("61G`B'S"U<(A\LB&5]%##$8G'(>M>BFD3W$E'J,Q!:4 MAH#K83HZC31JX=06PWQ%JINIB)@#/17SZ*RV:1+PQ.RTHX+."E M*@M")J**![.`8\L0S);W+&[J231S[N\&'G[_2+UEG.N!506I_M]F5_-AH,'M MSF&#N]]+%&=W;.]K3<(#`-,6`*)BM[?HM7:$.-Q;[6!W<;A+.]@__1UT76$S M;2&7NGSPMNB2>T$3/SQ">V=./N&#D[X,\:L@:]=*]0*SO2G,-H),.%N(V6[B M;->#B;4[L[NSV=N;VB4\X,+45P.\B]/L)I)(WF\?P<2-([W#UXZ,]4-E!\F) MMN[DM;,6;"]@LVU4$'[IZ%6_"[N3W)^ MMFNRM"=331P_RSH#IX)M#4QGQ[9W-T0>/OZ."KRVDG*[3/@^R`HDH)#WAUB$%2:6Y_R`O"?;O4 MQANPP*\HY88=3G`YD(AV!I+KU*16J[:[OPCE"EKY4=7_(H@8LONK__1J=#2X M,QQN)Q\N4;,G%G;DF,/!%A?,D87.GMF/M^XGBL$5#OJ?CKI+[T#2%)M'32,^P0T#+1*G.90H+H4 MDQ1_B)-'2#?E`@%53%PNYN5D6GB,P$S3HAS"RXQ!"1$55$P0IE37@>`9J`M( M6H$,']`T%;9&J%`3P42V&@NT-1WETN389ULS4\<@3UPGX<"Q&*-_`*42\=X MB^[DUD97Q1A(3QG5G`MUQ!(CDPP!5X-&TYA&KP&9^9,,T68!_8IJ,NDE_2&U M=K).A*%HUI;\6C55I5[DA8]040)O>T7=CPX#K^:N+59I.0L8+$)!8S@J@%4C MK!W$[Q1Z+%7GX+I`8^DP^,LG]*MX*LY6@;OS!4KXQ>N^*9[C^A_@$K4$!8SN M"D6,"%Q:17$!B*_/$`94\8S$!H#A56,<;5,>L$('ZZ'(I:#7W^ MJ+D"I1TND:M0K(BQ\+/[F,`T)>P7-U^M[N&9I*;7XY+:@S4-:^5R"=%J?$%. MH_VZ*3K.TFDM8>B)AV]!9`<9(`Y_EK@/-^4VMUY$.'B%Q"Z:VVK?0A)NZCO< MHO2-Y\0,&@-5+@K36(8Y85)Z51$HID;"\9^`;B<;"#%_T_A",%_I+&5);UQVXZWU1:E*4!CTCO:E\ M?5$!*:..P[G(L?@'N#SSZ$Y,@>U#9.;T/EBFZCJCTR3GMWM6WAU[5AG^0R14 M1?^+]^U$]/&?-\Y]JZFWCK!,'BFI*M:03`,Q&`RQ%!P?Q$+$`P&Q$A)7==":?=A33!_+T"60V`CU(+QKR;# M`RBBQ,21B'63)]QP'`Y7?)DGRQ@2)`%:?A;,YWY2W$?:V#7@RC3Z+)>H[GBQ MX0B^4#LE9F/V`&76DS@F5"'X9B+/VYGH7%\0O"G^&J02@O=G?X:^9FTC.$%5 MP4>5R\N?D9]Z$E6$+YZ26N==6C/-2[IJ)5VU8UYLNNA63QUGU!A>EB7!)"?6 MS.(W!PN]O4CTKR-AQCV1<+AX8R7QN2#O'6/X%"K,-G[M?:3]6MCI\?G4G%(J MM#/>YYIT0!JV"4/^C_)!`/;C`S8D.-9P[>MGL'G32OW]Z<%..`#^^AF'I-6* M'DZ(MXH>MOSI=S^K:/[S%1WD.,.S.]GY2\S[`(O:(MI]DA:XYLP`S=^?SZ&K MG0S;2B@\'6ZRU_^>T/OOHF`NQ`J@^&3^@EKJ)%C09L0Y=6*>20!E&-M;H%^_ M#/E#L=5UUOIZQ.`]V?&;.K@O]OW%ON^H??^^=`93\*->[/K3F6L'[?K?&T(- MD*C0$6NV;PZX_TOMOU^O_N>$Q#`Q+_WHCO,QHT?(C^!A*/"_5;*6/XB3N@?D'ZR,&ZFF.IG MCT<#LS%WQ-!S1RI9+44*2%-L7R4\J'0+REQ)?"/-,3N7$M<1+3@,%D%&0:)K MX_8^SD/(JJF;&J;MMJ$9P_SF3"AHZY9^;WWU>>T&3^B9@284P6)X93? M7*X5H`H$E7J'+0SN8/'@=[!ZY30JR))*!5$>YHH+SDNA'370`$PC9I@&D"\. M_SHGM.X/D?$U0,!UL;8!G)8,8=8Q)W^B.M3(G$6YFGK2X^K*@_-OYB\A12?* MJ&NVT&,>LGL82N5FRLS@\F<,[1.)!PU)*EVHN?OTM?'1B[P[2L::^&$@AN5, MT2"#K9Y._32=YZ$:7PTH^U<#`6*_$T04!.FB2$/6XD[>W/H#A%@>R?;$,B6I MW7H\2ZQHPJ190%33-/_PUY\XPO`B>^\]-[XN017WY1^IGIN$AD];W32CHDW`FMG]K!2C0GKMAB^> M(`L;5322]1M4DWT0]&Q.S,NPBW1*KEW<=R2:_=G&ANY^J7;6KOUGSNP7EP+R MQ*PU@^_8T;H+;FN<)6DFA3FP9ZYOI&,5/'ES2FH<\+LA[FE4@)>FJ#\85RG: MNT?S+/CP-W!D8"E*JZS9E][WUT[?,ON]T;KXP(O3-'172+K(QWWPY81*U\JY M?87'KU,R\W5O.#;'/:=3G.K8_16:+G)S%W3\SO677=KM$^7`[@K+DB-G"HZ< M.3AR+CQY\CS9,:G8,49\I\)H[(E,`>X#(Z3=80/'MLQA;QW*]HN;72L$723E M"S`HHM1TT`H?F[VU"4$O+CMHOE`"D@R0X0^P$1" M0FYNWQDCU[VJ(F%"F%=A!4+45L/"2=5Z06BTJ;Y(!YR!6"]C,]6EH2`EB!)( M`)R&1-BI`@T&D//FIQBXA=05`TB%K*@$!RSH\G$C$6:-4G\D8F(#!=>'8==& MSFN&//L9&KC[OP&\X8%9OREBC"M<1 M0)KF\V#J$SYJ>N\E_GT<2D"_S)_>1W"]XF)@78Y*1?!2*+.35QZ@]/G?IF&> M0KD>2M:44N0*\,E;L9>A__&]$,`9O#8EC(7P46:U+9,8\E^`U<18=(7!RSV) M3`KD84(?-(.-(X,`_<1G)KX",N6$*^#;Q)JY!QXT[$*+"@: M+F9$3PV)M#?`AR@#@JG0T4IC0GE"$NBPPEONT%+@67C:,$E,AR7UY(7,^9!( MA4R;6'I)]G@F&5V'S%[V379NP-ADZJIYFX;-U/&-?`W[;W5U8JSL?N$\_-2PK?9@HXUO0 M3HG[G?2H:7$O8-7-ECMVX$*T$:10;=?I^5+C]\32]H?FN-^5GC4OXM1J$F0' ML;X()YJOP8`;0DCK*B\97[5M(E1_"5^,O\`[-4]]**"1#2?L(57)F4:,I5+4 M/F699P8V2$C]Y&N`)53&KWGXR#U3;K1[689SR,F&K5=ZYF`XH%8C^/.P=;E% M(TK[!BZR_1O>+5US=0ZYS?UL__V?__%?/WR;)&'P!OXM_O?_`5!+`P04```` M"`#(7*]`*R.XBS0&```>)```%0`<`&]P`L``00E#@``!#D!``"]FE]SHS80P-\[T^^@NB_M`_&_ MI&U\26\()BZM#3[`E]R,7S#(L7J`?`(2IY^^*VQT3H!@'^;\D-CR[NJGU6I7 M[/CJ_2;PT2-F$:'A=:M[UFDA'+K4(^'#=6MF2;*E:%H+1;$3>HY/0WS="FGK M_9\__H#@=?63)*%;@GUO@(;4E;1P2=\AW0GP`(UPB)D34_8.?73\A(_06^)C MAA0:K'T<8_AB._$`]<]Z"R1)!YC]B$./LIFI";.K.%X/VNVGIZ>SD#XZ3Y1] MCLY<>I@YBR;,Q<*6/I@K/L%A',VGR<(G+C+QFK(8W#$WUC$)R'\8F1M8`H-A M)P;XN:4J\V[GP[S7Z?;F'Q*'Q;!&-?2P!\OJ=\]@5!V.9'-^?V..YW1GA8'* MV68)WADZ,7[?3;3#0GN5DP/YNCW\YPA&7XUHN%PK[P17O[Y;XH>1U\KV*74VHSXV\1+Q_Q"H8E9C:MZW^6`; M]C`)(,KDT%/#F,3/?$-9D$(">&IEQ?#RND77;"/QV.CTMU/]?(AN_+R&@QH1 M?LY:J'TDW8WC)H!*%[VM=3HBQ8E6MSY].@HHIU2/1X=DQ+"QO$DB$N*H$J5,OJ97DB!P MV+.QM,A#2)80`'!>7)!J-QUEI1[QE.&U0SQUL\9A5(U6(EZ7 M@4)TQL\\LWQ)R)I'2#5(N4X]FCN\B$B,A_@1^S2UJ]"H.A]5J-7T$)R;,#;) MPRJ.8,5:"*7F@2Q\+$?1`;GR0/5ZC!"A+,$'1U*)>#V&(5YBQK!GPBZ$":XL M:<7B-3,1C?'4>786?N7\!:+UYH8;;D!#*Z;NYZJY"T1K9Y*M-P^:OEBZ;DT" M4_RV#%4.POS.80PRYP%5Z4VU>DR[NAL^C+%SP*DH$:_'8&(?$H`']Y+XV8:U M18Y[T/VA2J\>U<3YES(EB6(:P--8%4NQ=#T"#1XX`VP[F^I]*1`]45PIQC"B85"A<7EGE$T"1;-W(C+(K874PYD3KWM46$?Z2@#WU$1^2)DKDWZ)P MF)N!%`GO3UCR_)<]AO('OXN48P4FF)LLL.01\$:4/G[M)MI?J;!"PK@-HNV= M3+O00//<8C+)HX%#CH3.:W\'XG0F*<#!`K,C<5^J-L_J^/YQA*E"\UPAC>5C MT3*=[QJ3>.DD?OS-09FIOV2&81(27C3'\/$%-][`G=S#7D;.#7YCQP:&N6ZG MT^DB"64:^V^=T$-;=?1"_]2TQ4T9@=<#)M$#@/<[<93)-XI3W)81;/TWV=`O M+]1_/3UK1;-&<)Z_XORJA^@2[6LV29COW@C`BS" M1*Y/(Y"$#[ILSTP5&;?H9F9INFI9#?CMN':.@/W]-:PUFTQD\Q.GM;21KMUJ MBJS;2%848Z;;FCY"4V.L*9K:P"+*&C^"]H_7M%-3GU/2-:![L-,FTY4W3X]7E5'*"/L=EX3WJDWEF:K:*A^5,=&BH<4 MP[*;\.&!K2$!V\VY4[8YGZF-_K*MU*>:;LOZ2+L9JTBV++4)[++ND<#LO<:$ M4V+.U";#L:R;))CZKYF&ZJUJF@!EPD;K,[6!E%C081(\Y[EL:$#03>5/,FS= MZ5F*.DZ"Y>(UBV),)H:.+-M0_FDDG16UGP1.KE!`-MOM54-$55TH@98O"QP( M&5-;,_3M`;R331,J0P,Q7M:?$G2Y,L!SK9P6I[$J-W+N*MM4`BY7"DQU#-EK M"#'/ZX$-3K-D)?7CZ3%+.E@97"]7!2;RWX:)E!GL[T0U&R`J:FH)G%R>UW0X MDBJRY?LF-K&\O26(UX"*9?11P;'40Q=44V]B5#/-\$$3"Z= MFZIE0W@W<[LI;8<)GEQ*MV8W%MRW^&V!U[LL/UVE/X(0/Q6!D?\!4$L#!!0` M```(`,A"TR,#$R,#,S,5]L86(N>&UL M550)``-H>+)/:'BR3W5X"P`!!"4.```$.0$``-U=_7/;-I/^_6;N?\"Y-]-V M)HKMI.U,_#9OAY8H1V]E227E?,SEID.+L,TW-*F"E&/WKS\`_!`_``*49')S MG6GBR+O0L^0#8+%8+'[][?'>1P^81%X8O#TZ?7ERA'"P"ETON'U[=&4/#'LX MF1RA*'8"U_'#`+\]"L*CW_[YG_^!Z'^__M=@@,8>]MTS-`I7@TEP$_X#S9Q[ M?(8N<(")$X?D'^B]XV_8)^'8\S%!P_!^[>,8TU\D7WR&7K]\=8T&`XUFW^/` M#O7U\&X8/S-21?HI>K4*\Y.]R0%<[;FIU]'OH>#N+H M\V)S[7LK9.%U2&+Z.#[/U[%W[_V-D?5(32#T8R>FX#_;YO#SZDW,^WC MDY^/3W]:OCH]>W5R]OHG30MB)]Y$N04GCR?I?XGZK[X7?#EC?UP[$4;T=0?1 MV6/DO3TJ/+>OKU^&Y/;XU@WP!2>2=11S>-%SQYZ_Q-4@JP?XUR,0& M[*/!Z:L!?6F/D7N4/7S^!$GH8PO?(&[F6?RTICTA\AB1C]+/[@B^$8/Q"3EF M^LDO[(N^2S^>.M?8/T),DO);:M>;4ENITG'78!>8>*%+ M:;X3ZJIV3_!IWR'Q'@84]3LW81G&CK\3^*)FY[!G>+/,68S1P:=M=4PP/&OXN-NVG;>>K@JM>NSP3(DY2<2KLGC M@,T[)Z^3$>^[^<+Z^">=8#;W=`HT`MI!8R]^8K,-N>>#K7$=Q<19Q5E#W(JW M1RWTCJM(60L&R>`Z9*6P.94X7H5T0EC'`S]YNHGZ#0GO6\%)'U+80NE/_SK_ MON3I4D@2PTIB!$?U? MC[=?M@NM4H.X,1%>O;P-'XY=[!US#X?^P"DW.#E-I]GOZ$=_)B@L?.LQY$', M7)N*U7*Q+BBE`LD8))/IG3`*8%5^I)38RG)/LS]:#"E7B>-/Z,#X^#M^DAI7 MD^N6&!*89694A`!10XQ,PHU4&'%I1,7[8$8%@*23!9/I\RWG2P:V7FZPI2+7]7L7PJP2H"0$B@DB9%)*),(LUL&#&'VP MPZ!`7`9F[#NW`KLJO^^*#4)8&0M*OP3Q]D6(JF\]ET%,J(]W/=P0PC!ZT>);&I'4[)IE@F.\? M)?LT\N671+SC-6PCZ,I25B@+B#V-`*4D^C[:[OFEFVLH;:E'-G$V#^D\>AL2 M>02D(M4M=X00RY0IB0!BB@B7)/*1;F&GLOT1(MF>'ONA4PW&2V2Z)8,`7ID* M!0%`1*BCDM`@S0[@DCW.,>']?1C8<;CZ8M\Y]'',-S%/U:!CEWQ8;%3J>+[1 M,*`RZS1H`"*2!DQ9:)5K(J[Z`B7*J*#=9PPN6=@E89\Q_4SDSC3(=AV+D\*M MQN-J@B"8I$(GCV)(X-;Y41$$1A,Q.MFF M1*(#@S5#)[HS`I?]9?ZU\1X2)^O@\EUMBNZ9NEZQJ94Z195J* M8%C7!FV-A50)T04<6K$?\%8=!B&-U2K<4#067F&*[-K'%R2,LAXFZX4*I4X' M-BT#2B-:SZN<1#A9GI)9+MD52/<(IF$ M@F`XU(2N2IU4%N%$&,KX5)SP=9R"'MTJI3L%AA#&>>@_8G00Q MQ>I1MRL!*!^15$I=\D?/@"*5FC7`L$H+9FUDLY"\;`.@*M7I%HL88FDWI2P"AC9B7+4]DE2* M$H6+P6!&8;Y6S^B]>4,*+P@,$^J8Q*LQ>+Y/(P7Z>/OR%P_LG3>_[OG2F")( M^UU3S[GV?"_V<$07>#Q)Z2[T74PBMMB+GQ1K)'WU+LG2UJ@BG71UP1"N)>`J M):<3XWPRG2PGIHV,V0C9R_GP]W?SZ;%'JBH\9. MK5P:(N7:[=D6%&%P*MM863A/;%-E21Q7L8O1J-''#ED#=-'VF$`<#*_4&*4; M8^M$!0U0S+1`LLO"/B\UY9!BSPG<&7W9;3BGTTZ/3-0WLX&?ZD:@LE8;N0:7 M2=(6_83$!SV;LA>GR0:[@BE`C\A:RAVSMX5!%W&@ MMR@`PQ(IM.;,`W!+@=:Q#RC1CG;QC6\@HM$ZAE%4^!XE*C!(53@VV)@#7!/K M=`-/`K*T95>1`4,6";!:!"(YA1DEIS#_^^7)R2GSJM$#TWF!?CXY>7&2_(^B MY(BFLXGO0L(V_UZ@TY]>G+YY]>*G-[]DO_58P1*79[F$SW.62I=\U`%?)&:3/!B&:H`4SJCH:ZH(@UB&Z_+C@XZ_<#QW$J3I&;+5KDRZ MT]A",^12,$$L"H9$S?AJX8)<&K'L\X$7#%:)`@PN63AVO`"[ID,"V@LB8[7: MW&]XL(VN9[V5-"E&1[%+AND;4B2;6@L,[[2A"B)6F2!R$TD8W*LO;[3707TO M+/46E&"X(X4F#DW`74:J]OAW3`V`E96Q2S8&&*II`A4G!'T[.1B%U?;"(7/" M*SVX?-&SP(07-U*OT^6:/44]5*9(`B$R-3"DU,D1:NH2">#+B%;51PBR208F\F55D3;:@$E&2]1K$VP3+I7:07Y@Q:-DYS$E4I M]4=#G:FT60,H[30GU!K=@,ZI(N,:I]4FA;[I)I]1M2Z2X9I8!!VJL)=OQ7IGAQI;K?K`W+;1V)I?HOG"M(SE9#Z#PAA6DR7!SRH?-KL*NDJ= MU\M1&E`KH2/5@,,N'9BU*67YSK309#:<7YKHAW1P^A$&U29!C.E#BA.;\LXC M#;=(I+L-7S5"+H>OA*)@Z-2,KQZ^2J21Q\5A$*C0(]1]IK=12#'D@"%$'9.X M5BDD!F2T3$=#!=5SJ3Z&C`I$T5"1BH!AA!B7=&A(%RTPF,&YJEK5EF4Z'Q\: M5[-%`3",$*$2KX.>Q_&0K&>9IWV.;T*"%R1\\"(O#,9A.I8MG4?Q0E=#J;,5 ML+8!^=)8J=$[9UK!%"Z0SLWQW#+1PIJ_G]ATB83H/S-*+8V/4!;9626(,7:I M$^7GQJ7]Y!P'^$9ZL$97N8_:'7H&B4IZ-&OV3LV=X-92`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`FH*R7^H)F)FZ-611UAY/-[FRS1$Z M_R3,-0'-VDGP0+V+`R12-38$@,4:AFJPN:$5Z*Q60UQ2:'9SQ;KA9$*;!CJMUMK:L%+U5FUM,.QM#;D6 M8J)H[JB3$;$MKG6JS/?U<:8)@[/IK6.LI#';6][0A9X=WL1?'8(U#X;#99\.S>ZCI4VK7;--'M^-K> MN/(@JZ\/AKT[@!;Q]X>1.;1,PS9_I.Q-V,R.5O$?V+5D[XVI.5ONS6))-0NQ M$>?XU@N">GTL/97.*EEH@L_K6"CD>V=6"Y#"-9&(-VB`SLV+R6S&!L7YF)WC MF\SW/K'7BDVFZ%YJ#?F>>636;J16"D-FD-ET%W43?4SZ\<&(T@V(HD@?E>**X$1EXMCOP1!'`*HVD+'# M.3R5AQV@`[=+G56B:N1$1:K[:@HUB/4:";D(('*(<*GXP2_*B9D2#(YDX^&, MOBOZXW8I'+AY7OUV60A'D)UB;E/FV!X?B!#&J?5 MT<0>3N?VE64RSV\VG_%YMA!#(S9D.0NR[\O%-R>=IH0^CS2!;E_')( M_KN1QP).@6P(;J'?;8V0EF:5"X9H*H,A>EO$DAMK(R:*/-X..\++CKY%-T_( M3;59:KO/+AUEOUSG5_!QM6=:)L_"&$?+,.VNCI\7/6F\)D='J[,EL[X)^<)9 MK=([]=KAK$7SF")C4:ZZO8(/B'LQJW@UOW`RTO#^L2+'TXN9I/Q9&C,EM3'&\ZO9MSY M6\RGD^$!]M4DDV-Z%"?_F2"O=-&!UV]'K&Y,"8C8#=0 M25-R5,.5CF*W=V'K&E*^$UNEU3O76D,5%,)>F-;R$U^"LGV*!5NR/M-0E&;# MC+9Y,(VC4:-X9P.2!NA\3&J0[9TJF@#KQ7S/[?P/] M0%[5Z@Z[&Q_S,AG4LJGWP`]@41.\:Q\GAU27[`R6TL7:I:5._:W=32TY7^V; MZ9V[^V.OC7O&DC'98I6J;3[X369+8W8Q.9^:R+!M\]DR1-)S5JEGT#@`2D4[ M&_P48/.!3R+7.W$TP-7.P0V'UI4)S16K'*3:AJ%5PYJ.8A_WDZ@-$=U-(M?J MG6JMH=9.P9ECT[(H\Y[W!G$>54M/TJMII*?2;9A4#;X<(Y7+]TZ:%B!K<:XY M]#SEC/E7[&(_Y\;Z"1'V*Y[M+-&F!NT\P$0C!>?P.RVA;,_/)R/D/V M!I9HI3N-AC0"+D<`1"*]LX;/7R"(%,ZPP`BT-:EYS;UB.F-63W=Y&?_[$SC>&@2HJNV-#G7F# M>QF:NXL[M=([*?>&7B6G94X-=I/;PF![!$LZ@MHL.XT.JC#&T:VMZ7+[_.G2 M^7=(AILH#N_I%'+^9.$U.Z8;W-KX-CEQWBX:O'O#_?@3^SX(L6.Q:ZN]=XF# MFU+M(I?&O^86&EY1E^/2M(#TBSQY6]^C:%;I)6E>TVMHD@?#/PV056;I7DO\ M_W$F?06EMMD!;)![?(?:8Y#X?!,U;`+A\LE@B# MH90*83V[]=PV_[ABJ11LT[(YO/:\+N/SW3[1K2^B<"+UX=;W-*2-\>)YO#F4M`>&!P_,O(AWH0DP+_$@%:\AOSX95LUWEU?!MJ15L(L?3>E/]./L(_H'NY"0?O)_ M4$L#!!0````(`,A"TR,#$R,#,S,5]P M&UL550)``-H>+)/:'BR3W5X"P`!!"4.```$.0$``.U=7W/:2!)_OZK[ M#CK?R]T#_IOL;KS);0DL^[C%0`2.DRI7;0DQ8&V$ALQ(MME/?ST2PH`TFA$" MS^`D#XF#NX?N_G6/>GIZ1N]_>YKXQ@,BU,/!AX.3P^,#`P4N'GK!^,/!3:]F M]AK-YH%!0R<8.CX.T(>#`!_\]I^__\V`/^__4:L9EQ[RA^?&!79KS6"$?S7: MS@2=&U/CX^'`7YP'C'Y2@]=+#=<#T?$18NQVN=W#=]#04CO MNM'`]US#1E-,0C#'76<:>A/O+V383Z`"@8^=$(2_ZUF-NY/CCW>GQR>G=Q\C MAX2@HQ4,T1#4.CLYA$^MBRO3OOM#X*`9;#IQ%8Y$)X9L9]]'QVZ.3 M-_W3D_/3X_.S-Y(:A$X8T84&QT_'\S$^WO?"[Z>L[\&#D4&P!W0\R?J?3A8 MLMOCV2$FXZ/3X^.3H\_7K9Y[CR9.S0L8["XZ2+G8*'E\)^_>O3N*?YN29BB? M!L1/O^/L*!5G,3+\UBN@7Y*$>NY9Z@T8<#/"5/-0;X\5GR5?^4X0UG4X@^ZK'@.3".2DI7=WQFP=X]0B$5 MB9-+O,7O[SH$E+U'H>508,WAG.V,SR+?*FS$/$ M@O!YJDESBP;4"]$%>D`^CL=M8"J>CP1L%2T$<1.$MC>^#REHW`S@43/V!CXR M*968*R79J\D('DHB).U)'/)J,ER@$2($#6U`(8B0\)&63UYQ)L(AZCHS9^`+ MOS^'M-IW0]HZP4$OQ.Y7T7?GD%:>21)K2GU]/G759Q(,Q5)@>,J!F]\ZA,#, M*?%4*F2K)M/\N1N,6\B1B`H.>349;.3#!#"$O"2<]4$WZKA2^8.(KYI4U\Z? MF#0B&N()++%$LN135Y.@":O(">H[3V)<R\R67H9H<5QB&;&!(7HEP M!9!'6]4S:9H2BITQ0UHU5QM0]"V"\:P')#--<.B+I)@21($V3KQ;\,$*"WJ" MIS(LP=.!F%0;KMG@8\8+*^H3HV:D',L_.L'02-B-9?ZYM*F\/G971/39`A83 MH6^"L'\4R6D.:$A@]D@'\IT!\N/A_V"\\I*;(/1SCAZ,A\H[B M6@;\$"M2.SZ9+ZC_"1_]D'(0&:$(JL`(E6D#\,*XC"I/5)(87V[')MF=Q MSLIAD83E%PUA*;:".G1B+VG`E#K&I'@AL48IB<4[#;'(U5D=!$F_PJ6/'5XE M((=.>A6GH?US%%8X/3U7_'OWH#CM1&'<-`-!6CQ)%3+*XJ/E,EO")"I7@4DZ MF*R)+N$SWL.D@%X6'CV7XUP#J$>%)>GRF"Q1RR*BYP*=HWP.'N^/,NJUX(.M M%\CS.X$6%?%3HV8L&D_@YSFY,:>OZCPCAPYB'"):&SO.-/$@Y(8? M_[$0JC.Z]`*0R0-/Q]23*)C+L58.C,UU2QH+!%JL$ZDLFYG MJB#,\W$I+#*T2DOHU3#AZ*T'-*S[#69@]@]K7WIP?!"5FF'#(60&R4?<*!P`,?71%,4V5Y\25@4EJTET9+3G4]8%IM M52Q&AT.KM*`O#4JAHGI@L:*+S!-(<15_*T\>O2!(&V:[OI,D_VG7;!OQHZ*( M16DI?U.`9*R@!UZ=\!X1J30ZEU)I77]3=`ITU@,4T,8+4%1^`BVX(,D8E*Z"2`)DISB>H#4 M0VY$O'!V@:9L8N#5.=:IU&X&2.+`T4T/PR_I('Z>J*[N;^%!HI?U"PU?UN:[ M6;I7RWWU,G?+#Z(C=K(CWN>YQSY8C[+$+YP),BMY=K4U_4TA*VL>[4"5 MJVT6,<@"MYLU_A:`T[K,F=:+YH?<^L09"BHQA1RR8.VF*"!A])Q268'J6F*T M=.AK2=%@V,:!6P8YF7%D\=Q-#:$2GO)FT@9E=MPV1VD%2.J?? M0A9_NIOJPJ80[4O>OM1L5[B]G2&3A657-0BA>7&1]#I!L'KK0A$*N92R0.RJ M,%$&B`)5]<`BO6<"\HWD9A9Q.VXQBRPZNZI!E$%'1GD]8#*'PW@&AKG8\8;- M8%YDYV7*/&I9<'959R@#CD!E/7"Q4>AX`1I:#@G`:2CD\]$DBA=ED$-Z+G=/ M0891%JU==1^404O>$'H`E]5..E.3!T:OK@.^RGI`(JH#;U@>EX=+KS8$67/H MTO.>?^'DH@'^K+`!WOC7"ON_?S3$[WKQ`_;ND%C@89R6=A&)#Q^)UT-\SGUL MG2]A$CVFR]E;+V$#3<&*C^M+`Y52*^VBWQI(J[KK M`=#J`KWDI"C+K+2M?O,FU3*6T1%-R>E1Q*2T_WX[Z.D]2>;)6CA/%C'L9<>^ MV`(*LWS!!>Z+#/_-6H;_S&?@D;'$J<[3D@M4%X()TGDNM=*"4[PC*>K&SY*I MS,T%9E^M(^7KI\=,U7-\1.T2R8*K)D2M/5$G;D*:B'VW*OREYO=,_2*^L9<"4$D+*@T.$.Y40BLJ:D'!K$ZHCQSE4;MD["R!'CEK*$'@L\Y^26HW<#L_9(19!?96G-N?;:84>W)RA+(R5M! M#]1N$>N814/S`>0;HW8T&2!RX?D1?):YQ=8<_AG1L]Q9N.IO8P9@E\ M*]I+#]#%3MI%I.Y0SX6L:EFYC2.8.Y[:4YM;#6R!S339^LN^*GFQ\_>V<.>/ M,1H)IQ9=?0M%Y+OY/RZ(RZ&WN:'TF&Y!?F%!=HU&Z59C!7MCKD8Z`?+\7*9];",7!Z[GHQ6! M^W@[L;F;K]*ED5`J?'=I;3W\Z0(!`*Z7F#\8FA/VLIJ_5EZJFEFQ%G"HO;YW MEVAA20OH!&Z:RWZVZ.YC+Z*F\?G1 M"X\F-[/PIG-I=J5;V"^%>%EKZN$#8`2"P$TO4/(OJ,V*T\^Z)Y8[D-Y^7'41M'\9+@2ZTHN8>L*1^6=Q7 M6)5W?;P8VCD6>XUSO]QEC!)\ROM3=N\9XEL=]]0MY.ONE3>"5/?"[&X+2*\G M`4?N9O``3[`M[/$5#J3-=>15()8PE1Y00RXZ+[B9[K?(B_ON\E\/Q8&XS`!J M^V4J0(4WTUC".Q\R/-K;8S9CL0ES25'OC*JUYYKE9]R_GNYFB](,U_ M,6SR)OCU!),;MV6&4'M+>EE8-S'/CEKW\T6IH[$7!/P#6D(N;>Y+KX!'Q@@O M"H%5=)=P,8LV-Z%7,+ZEX6W"O6@Z]6/5'#]5K1F,,)DX,K<WD._/B<8`;#19?)<[+)^DQ\3"-8513/>=6'57WU>OEGV3;,J(=3Q+>J M)?>I740$1$\RU/@BP_AW%QY;E@2\V"W!K_;.]JW!MGYM>!GC*3ROTG9"T*8S MJD?4"Q#-.:KRDU$SGO6&_[3-_HUM&9U+HW[3:[:M7F^C4RJ'$9 MX//)&%'95H)19:EC;FCA&3@KFDP<,NN,>MXX\$:> MRXJ?27\#BU+L>^YR/641`C^OAT#OYOK:M+^P&.@UK]K-RV;#;/<-L]'HW+3[ MS?:5T>VTFHVF]2,T9!XV16CT`=LZ?/E7WI-&DGG_0JB<612&U;R;+'/CQ")^ M?EF/GZYM=VVU^Z_;K[=UES5G*U(<$&+&?0P-67,H#));-*!> MB"[0`_)Q+%U\#B43)R?'ZW%R:]5[S;YE7%B?K%8G#A*CT>GUO\]'0-:.(J]=L??T@K!O4?#R$?QP3?PEY;W@#)P]%F#LG"YL,E( M^Q=7%0RF,-[FCPT=6"MTS2\FY$NO.R**!)W;2]Z_A5S[Y]R2AE#HV4MO[\MZ]MMU MSVYTKJ\[;:/7[S1^_RX]>\E<(G?.)]T_'RY266W]?NE=:EG?S>P`=^TT6?D. MW'<7;^R3J/7G4^^?SPL45WI5)\C1F<:;TV8PO'4(<8*\JDYV^Y=YO='I]IN= M=E+5N35MVVS_*.:4*^9D7]'.1$^!Z)"D\B9?TBD]WOZ%4V7C*0RXQ1'2%CO= MD!-HF7UBMJ=FQOT4+6=+;^9*K%R9]1"E*(2BX4MPUSFME"[]W4>];'&]9@ MRWJF?NR^R-UDLFIG83+%I]^_8!`J7RH`YK]A?PT`L``00E#@``!#D!``#E6UESX[@1?DZJ\A\0/24/$G7,S,9:>[M&9>6_<,RVJA7W_YRY\1_)S_M=U& MEY1$X1"->="VV(+_C&R\(D-T11@1..;B9_0)1XFB\$L:$8$,OEI')"8PD,TT M1(-.?X[:[6>H_418R,7,M;9J[^)X/=2TAX>'#N/W^(&+K[(3\.>I\W@B`K+5 M90]OC8@2%LO;:3*/:(!]^-M MO]OKWWY,L(C!1Y.%)`2W!KT.4,WQE>[>WHS.[_?&_:[P\&[9WH0XSB16P^ZFV[^DXF?R^".K#""!\OD16L/K(=!AXNE MUN]V>]K-]<1+^5H9XW`34?;U&'OO[.Q,2T<+U@KG9BZB0O5`4\-S+,E6,XS2 M$_R4R1BSX(`_C+<"^\SOM6SP@)4>9?V0L=*"-20E/DF"SI+?:S"@J6?1[O;: M@U[!GLCV$N/U5F2!Y3Q5G0\<$6&%CH4 M`!,461XU+ATY8ITS=6^V`NHFY>D.%`>)R`J6P"47JS%9X"0"]+\E.*(+2L(6 MBK%8DE@%GUSC@-1H*2(7,\;C=*'D%$5;KRE$,!#^=*["8RAX1'RP%*D+6-N' M.A51@[!/E%4Z"TT6T_A1K0&Q2C6W$`TO6B=:6<6>XD22T&&_I-=K022H284F0,@%O[>*+RWL$AGX:Q)=DKGX5LS5H_SNQ+..P6(+]!. M16,1-K"\NXSXPQ&`=T/U^+X_B:_2@%(5C<+7AHQ.$&L*]NZM`S=]I%N&,[,]BW["DV= MB6589K,>RE20-::AN5D3)@OTR\1ZF/]1AGGJFE/=&B/S9FK:7N/`Y'`6Q8\J M^?V6T+7:0@M$CXS4PWI6A=69FJ[_!>DV8/MQ9DVO3=MO%+B?R5S2F(S)/8EX M"J#!99$1UPW60MSKEB'^;(X\RS?1V/QD3IP47V0XGM^P$(:3G\4N7=[%$H+5 M`G?8DLXCHDNYK3^>8JI'O5<);-U70+O6U3]]+XUNR_9U^\H:34RD>Y[9,/SA MD!,)*>W'96(]OOTROG"^N3.SH?OQF"R($"1T85M@"V8V"DR;QV2*'S$L\SP5WB/4@_BND@4[L,E.]2\ZK/!&`6CPU8HS M+^;!UPS`?4(]@._+`!K.];5C(\]WC'\W"D!(2[.ENX=AB58/8Z4:@TPU7\W- M0S(%2WU*X4P=X)^Q$%!@;=\>'!^LQ[9:;"E$D3/U+UJH34V_:8>X2L(6$4PQEE`\1*7&P]TZQ=K0> MWDJ1Y9H3R$;'<#BI2LN'>/5T(PWA1@%]C7_GPDADS%=$Y/"6:+6@]BMEU;7^ M+\=%Q@RVA&O3;1:2%@L`+Q]OBK6_3ZC'L%(D63:<^2;R]9N&K?GM7GE8#U7) M]6!6*J+=)MK(FNB*`VX&9P$1^2?;`TH]D)5JZ,I1(!J.;9BNW2@,72*++R3% MZ;,CU"-8*859>I6D M2O/_ISQ3_5*M.RY9H+3E9ZC:22Y:DJH&KE9.NX,ZZ*+%UV+3+KH_?@/7.IM5 M5+`HU2=:?M(G4T8CG[A0@450T5)I20(EZ;J3M^HWR^W)/ MTCDXSD6,6*6IZ51_6M99-^%!JNJ$B+IK%W)M16KW^NU!K[.1X<[2EQBQ@^%E M1A1RKS#B=%=9C1FI"4>;Y302Q7*KJ[W3]5Q[3G;MG3*G+*,N7C'_R1;`U\.A M**^PYAGMA<^)E'U).Q-4H7*F0J7WX;\TYG6&/&5%WJV89>=PSO]VJ@]0G\M8 M0'W>2JT^W3.XX\7YU44K%NI=/J-1I-X]%_=I2^L0MBC*0S_=2<-$Y)V)V64BT7Q47:G2G^SII=-?IEIV=@\ M:WJ#`3*G\:'!*\Y(C,7C=S!YPJ4<$8@+,A7\GJJ.]4LN#BKLS)?G,+[>R4"0 M\`=ZJ7JM8!FH/ZI/X!Y'*A,>D25E#!Y]X>/3;&_U,1ZWW&3AD]YM>=ZJ:^I[ MF/3Y)64P&\71KHNNO$,\A_/-[1FEIB"?;.)1E'Z'R9PZ,?YBT[.V_6%G&9Y"TX<-@)4'*@??@O&IU&??S#>%>\5)YYF>PO.['V[K7A0,_86 MS%;_7Q0F$=DV7JLW?S+-O+*@&3VJ?PR#3?'(^GBM\%MP?/\E9\6QNL'_K>'G M6I:3P^5_`%!+`0(>`Q0````(`,A`Q0````(`,A`L``00E#@`` M!#D!``!02P$"'@,4````"`#(7*]`6`B`3!@7``!0(P$`%0`8```````!```` MI($_0@``;W!R>"TR,#$R,#,S,5]L86(N>&UL550%``-H>+)/=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`R%RO0*RA]@G"$0``].X``!4`&````````0`` M`*2!IED``&]P`Q0````(`,A XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 4 94 1 false 0 0 false 3 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://OPRX/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Balance Sheets Sheet http://OPRX/role/BalanceSheets Balance Sheets false false R3.htm 0003 - Statement - Balance Sheets (Parenthetical) Sheet http://OPRX/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 0004 - Statement - Statements of Operations Sheet http://OPRX/role/StatementsOfOperations Statements of Operations false false R5.htm 0005 - Statement - Statements of Cash Flows Sheet http://OPRX/role/StatementsOfCashFlows Statements of Cash Flows false false R6.htm 0006 - Disclosure - NATURE OF BUSINESS Sheet http://OPRX/role/NatureOfBusiness NATURE OF BUSINESS false false R7.htm 0007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://OPRX/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 0008 - Disclosure - PREPAID EXPENSES Sheet http://OPRX/role/PrepaidExpenses PREPAID EXPENSES false false R9.htm 0009 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://OPRX/role/PropertyAndEquipment PROPERTY AND EQUIPMENT false false R10.htm 0010 - Disclosure - WEBSITE DEVELOPMENT COSTS Sheet http://OPRX/role/WebsiteDevelopmentCosts WEBSITE DEVELOPMENT COSTS false false R11.htm 0011 - Disclosure - PATENT RIGHTS AND INTANGIBLE ASSETS Sheet http://OPRX/role/PatentRightsAndIntangibleAssets PATENT RIGHTS AND INTANGIBLE ASSETS false false R12.htm 0012 - Disclosure - ACCRUED EXPENSES Sheet http://OPRX/role/AccruedExpenses ACCRUED EXPENSES false false R13.htm 0013 - Disclosure - DEFERRED REVENUE Sheet http://OPRX/role/DeferredRevenue DEFERRED REVENUE false false R14.htm 0014 - Disclosure - NOTE PAYABLE Sheet http://OPRX/role/NotePayable NOTE PAYABLE false false R15.htm 0015 - Disclosure - COMMON STOCK Sheet http://OPRX/role/CommonStock COMMON STOCK false false R16.htm 0016 - Disclosure - PREFERRED STOCK Sheet http://OPRX/role/PreferredStock PREFERRED STOCK false false R17.htm 0017 - Disclosure - STOCK OPTIONS AND WARRANTS Sheet http://OPRX/role/StockOptionsAndWarrants STOCK OPTIONS AND WARRANTS false false R18.htm 0018 - Disclosure - OPERATING LEASES Sheet http://OPRX/role/OperatingLeases OPERATING LEASES false false R19.htm 0019 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://OPRX/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R20.htm 0020 - Disclosure - MAJOR CUSTOMERS Sheet http://OPRX/role/MajorCustomers MAJOR CUSTOMERS false false R21.htm 0021 - Disclosure - INCOME TAXES Sheet http://OPRX/role/IncomeTaxes INCOME TAXES false false R22.htm 0022 - Disclosure - OPERATING EXPENSES Sheet http://OPRX/role/OperatingExpenses OPERATING EXPENSES false false R23.htm 0023 - Disclosure - GOING CONCERN Sheet http://OPRX/role/GoingConcern GOING CONCERN false false R24.htm 0024 - Disclosure - RESTATEMENT Sheet http://OPRX/role/Restatement RESTATEMENT false false R25.htm 0025 - Disclosure - SUBSEQUENT EVENTS Sheet http://OPRX/role/SubsequentEvents SUBSEQUENT EVENTS false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Balance Sheets Process Flow-Through: 0003 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 0004 - Statement - Statements of Operations Process Flow-Through: 0005 - Statement - Statements of Cash Flows oprx-20120331.xml oprx-20120331.xsd oprx-20120331_def.xml oprx-20120331_lab.xml oprx-20120331_pre.xml true false XML 40 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6

MAJOR CUSTOMERS
3 Months Ended

Mar. 31, 2012

Notes to Financial Statements

MAJOR CUSTOMERS

The Company had four major customers that accounted for 74% and two major customers that accounted for 76% of the Company’s revenues for the three months ended March 31, 2012 and 2011, respectively. The Company expects to continue to maintain these relationships with the customers.

X

- Details

Name: OPRX_NotesToFinancialStatementsAbstract

Namespace Prefix: OPRX_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-Paragraph 39

+ Details

Name: us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Balance Sheets (USD $)	Mar. 31, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 797,503	$ 959,166
Accounts receivable	116,458	471,870
Prepaid expenses	114,000	119,032
Total Current Assets	1,027,961	1,550,068
Property and equipment, net	24,055	23,931
Other Assets
Patent rights, net	834,265	847,941
Website development costs, net	466,686	465,498
Security deposit	5,049	5,049
Total Other Assets	1,306,000	1,318,488
TOTAL ASSETS	2,358,016	2,892,487
Current Liabilities
Accounts payable - trade	176,051	336,712
Accounts payable - related party	570,000	570,000
Accrued expenses	322	66,000
Deferred revenue	203,153	330,605
Total Current Liabilities	949,526	1,303,317
Stockholders' Equity
Common stock, $.001 par value, 500,000,000 shares authorized, 14,192,496 shares issued and outstanding	14,192	14,192
Preferred stock, $.001 par value, 10,000,000 shares authorized, 65 shares issued and outstanding	0	0
Stock warrants	20,826,934	20,826,934
Additional paid-in-capital	5,245,612	5,125,558
Accumulated deficit	(24,678,248)	(24,377,514)
Total Stockholders' Equity	1,408,490	1,589,170
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 2,358,016	$ 2,892,487

Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2012	Dec. 31, 2011
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Issued	14,192,496	14,192,496
Preferred Stock, Par Value	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Issued	65	65

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2012
Document And Entity Information
Entity Registrant Name	OptimizeRx Corp
Entity Central Index Key	0001448431
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	14,192,496
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2012

Statements of Operations (USD $)	3 Months Ended
Statements of Operations (USD $)	Mar. 31, 2012	Mar. 31, 2011
REVENUE
Sales	$ 329,403	$ 393,843
TOTAL REVENUE	329,403	393,843
EXPENSES
Operating expenses	630,322	634,281
TOTAL EXPENSES	630,322	634,281
LOSS FROM OPERATIONS	(300,919)	(240,438)
OTHER INCOME (EXPENSE)
Interest income	185	440
Other income	0	66
Interest expense	0	(140,000)
TOTAL OTHER INCOME (EXPENSE)	185	(139,494)
LOSS BEFORE PROVISION FOR INCOME TAXES	(300,734)	(379,932)
PROVISION FOR INCOME TAXES	0	0
NET LOSS	$ (300,734)	$ (379,932)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	14,192,496	13,628,067
NET LOSS PER SHARE: BASIC AND DILUTED	$ (0.02)	$ (0.03)

Statements of Cash Flows (USD $)	3 Months Ended
Statements of Cash Flows (USD $)	Mar. 31, 2012	Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$ (300,734)	$ (379,932)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	46,023	30,050
Stock-based compensation	120,054	0
Amortization of debt discount	0	125,000
Changes in:
Accounts receivable	355,412	(112,911)
Prepaid expenses	5,033	61,467
Accounts payable	(159,640)	210,735
Accrued interest	0	15,000
Accrued expenses	(66,700)	9,300
Deferred revenue	(127,452)	(50,270)
NET CASH USED BY OPERATING ACTIVITIES	(128,004)	(91,561)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(1,424)	0
Website site development costs	(32,235)	(37,610)
NET CASH USED BY INVESTING ACTIVITIES	(33,659)	(37,610)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS	(161,663)	(129,171)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	959,166	1,278,094
CASH AND CASH EQUIVALENTS - END OF PERIOD	797,503	1,148,923
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued to satisfy dividends related to preferred stock	$ 0	$ 250,000